Healthcare Realty Trust Inc 8-K, filed Aug 8, 2023
Healthcare Realty Trust Inc (HR)
8-K
2023-08-08
For: 2023-08-08
View Original
Added on
July 07, 2026
About this 8-K
Healthcare Realty Trust Inc filed this 8-K on August 8, 2023.
Items reported
- Item 2.02: Financial results
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 8, 2023 (August 8, 2023)
(Exact name of registrant as specified in its charter)
| (Healthcare Realty Trust Incorporated) | |||||||||||||||||||||||
| (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) | |||||||||||||||||||||
| (Address of Principal Executive Office and Zip Code) | (Registrant’s telephone number, including area code) | ||||||||||||||||||||||||||||||||||
www.healthcarerealty.com | ||
| (Internet address) | ||
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||||||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):
| Healthcare Realty Trust Incorporated | Emerging growth company | |||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Healthcare Realty Trust Incorporated | ☐ | ||||||||||
| Item 2.02 | Results of Operations and Financial Condition. | ||||
Second Quarter Earnings Press Release
On August 8, 2023, Healthcare Realty Trust Incorporated (the “Company”) issued a press release announcing its earnings for the second quarter ended June 30, 2023. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.
| Item 7.01 | Regulation FD Disclosure | ||||
Second Quarter Supplemental Information
The Company is furnishing its Supplemental Information for the second quarter ended June 30, 2023, which is also contained on its website (www.healthcarerealty.com). See Exhibit 99.2 to this Current Report on Form 8-K.
| Item 9.01 | Financial Statements and Exhibits. | ||||
(d) Exhibits.
| 99.1 | |||||
| 99.2 | |||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Healthcare Realty Trust Incorporated | |||||||||||
| Date: August 8, 2023 | By: | /s/ J. Christopher Douglas | |||||||||
| Name: J. Christopher Douglas | |||||||||||
| Title: Executive Vice President - Chief Financial Officer | |||||||||||
Ron Hubbard
Vice President, Investor Relations
P: 615.269.8290
News Release
HEALTHCARE REALTY TRUST REPORTS RESULTS FOR THE SECOND QUARTER
NASHVILLE, Tennessee, August 8, 2023 - Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2023. The Company reported net loss attributable to common stockholders of $82.8 million, or $0.22 per diluted common share, for the quarter ended June 30, 2023. Normalized FFO for the three months ended June 30, 2023 totaled $149.8 million, or $0.39 per diluted common share.
Salient quarterly highlights include:
•Normalized FFO per share totaled $0.39.
•Merger Combined Same Store cash NOI, including the Company's share of joint ventures, for the second quarter increased 2.1% over the prior year, and 2.9% for the trailing twelve months ended June 30, 2023.
•The Company merged with Legacy HTA on July 20, 2022. Beginning in third quarter of 2022, the Company reported combined company same store results, which are now referred to as Merger Combined Same Store. Merger Combined Same Store includes the Company’s same store properties, including Legacy HTA properties, that were owned for the full comparative period, and that meet each other element of the Company’s same store criteria. The Company presents the combined companies’ same store portfolios to provide an understanding of the operating performance and growth potential of the combined company.
•Predictive growth measures in the Merger Combined Same Store portfolio include:
◦Average in-place rent increases of 2.7%
◦Future annual contractual increases of 3.0% for leases commencing in the quarter.
◦Weighted average MOB cash leasing spreads of 3.0% on 598,000 square feet renewed:
▪6% (<0% spread)
▪16% (0-3%)
▪62% (3-4%)
▪15% (>4%)
◦Tenant retention of 80.5%
◦Year-over-year absorption of 26,000 square feet resulted in an average occupancy increase of 20 basis points, to 89.0%.
•Portfolio leasing activity that commenced in the second quarter totaled 1,041,000 square feet related to 306 leases:
◦736,000 square feet of renewals
◦305,000 square feet of new and expansion leases
•The Company executed new leases totaling 376,000 square feet in the quarter that will commence in future periods, an increase of 57% over the first quarter.
 | HEALTHCAREREALTY.COM | PAGE 1 OF 6 | ||||
•The total portfolio leased percentage was 88.9% at June 30, which was 150 basis points greater than portfolio occupancy. The portfolio leased percentage increased 30 basis points from the first quarter.
•Since the end of the first quarter, the Company sold three properties totaling $21.6 million. The Company expects to generate over $300 million of proceeds related to properties under contract or letters of intent that are expected to be sold by year-end.
•Net debt to adjusted EBITDA was 6.6 times at the end of the quarter. Leverage is expected to decline from additional asset sales and underlying portfolio NOI growth.
•A dividend of $0.31 per share was paid in June. A dividend of $0.31 per share will be paid on August 30, 2023 to stockholders and OP unitholders of record on August 15, 2023.
•On Tuesday, August 8, 2023, at 11:00 a.m. Central Time, Healthcare Realty Trust has scheduled a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends. Simultaneously, a webcast of the conference call will be available to interested parties at https://investors.healthcarerealty.com/corporate-profile/webcasts under the Investor Relations section. A webcast replay will be available following the call at the same address. Conference Call Access Details: Domestic Dial-In Number: +1 833-470-1428 access code 294698; All Other Locations: +1 404-975-4839 access code 294698. Replay Information: Domestic Dial-In Number: +1 866-813-9403 access code 594252; All Other Locations: +1 929-458-6194 access code 594252.
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June 30, 2023, the Company was invested in over 700 real estate properties totaling more than 40 million square feet and provided leasing and property management services to over 35 million square feet nationwide.
Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, without limitation, the following: failure to realize the expected benefits of the Merger; significant transaction costs and/or unknown or inestimable liabilities; the risk that HTA’s business will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline; general adverse economic and local real estate conditions; changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in the Company’s proposed market areas; changes in accounting principles generally accepted in the US; policies and guidelines applicable to REITs; the availability of properties to acquire; the availability of financing; pandemics and other health concerns, and the measures intended to prevent their spread, including the currently ongoing COVID-19 pandemic; and the potential material adverse effect these matters may have on the Company’s business, results of operations, cash flows and financial condition. Additional information concerning the Company and its business, including additional factors that could materially and adversely affect the Company’s financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in the Company’s 2022 Annual Report on Form 10-K and in its other filings with the SEC.
| HEALTHCARE REALTY TRUST INCORPORATED | HEALTHCAREREALTY.COM | PAGE 2 OF 6 | ||||
Consolidated Balance Sheets 1 | ||
| DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA | ||
| ASSETS | ||||||||||||||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | 3Q 2022 | |||||||||||
| Real estate properties | ||||||||||||||
| Land | $1,424,453 | $1,412,805 | $1,439,798 | $1,449,550 | ||||||||||
| Buildings and improvements | 11,188,821 | 11,196,297 | 11,332,037 | 11,439,797 | ||||||||||
| Lease intangibles | 922,029 | 929,008 | 959,998 | 968,914 | ||||||||||
| Personal property | 12,615 | 11,945 | 11,907 | 11,680 | ||||||||||
| Investment in financing receivables, net | 121,315 | 120,692 | 120,236 | 118,919 | ||||||||||
| Financing lease right-of-use assets | 83,016 | 83,420 | 83,824 | 79,950 | ||||||||||
| Construction in progress | 53,311 | 42,615 | 35,560 | 43,148 | ||||||||||
| Land held for development | 78,411 | 69,575 | 74,265 | 73,321 | ||||||||||
| Total real estate investments | 13,883,971 | 13,866,357 | 14,057,625 | 14,185,279 | ||||||||||
| Less accumulated depreciation and amortization | (1,983,944) | (1,810,093) | (1,645,271) | (1,468,736) | ||||||||||
| Total real estate investments, net | 11,900,027 | 12,056,264 | 12,412,354 | 12,716,543 | ||||||||||
| Cash and cash equivalents | 35,904 | 49,941 | 60,961 | 57,583 | ||||||||||
| Assets held for sale, net | 151 | 3,579 | 18,893 | 185,074 | ||||||||||
| Operating lease right-of-use assets | 333,224 | 336,112 | 336,983 | 321,365 | ||||||||||
| Investments in unconsolidated joint ventures | 327,245 | 327,746 | 327,248 | 327,752 | ||||||||||
| Other assets, net and goodwill | 797,796 | 795,242 | 693,192 | 587,126 | ||||||||||
| Total assets | $13,394,347 | $13,568,884 | $13,849,631 | $14,195,443 | ||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||
| 1Q 2023 | 1Q 2023 | 4Q 2022 | 3Q 2022 | |||||||||||
| Liabilities | ||||||||||||||
| Notes and bonds payable | $5,340,272 | $5,361,699 | $5,351,827 | $5,570,139 | ||||||||||
| Accounts payable and accrued liabilities | 196,147 | 155,210 | 244,033 | 231,018 | ||||||||||
| Liabilities of properties held for sale | 222 | 277 | 437 | 10,644 | ||||||||||
| Operating lease liabilities | 278,479 | 279,637 | 279,895 | 268,840 | ||||||||||
| Financing lease liabilities | 73,629 | 73,193 | 72,939 | 72,378 | ||||||||||
| Other liabilities | 219,694 | 232,029 | 218,668 | 203,398 | ||||||||||
| Total liabilities | 6,108,443 | 6,102,045 | 6,167,799 | 6,356,417 | ||||||||||
| Redeemable non-controlling interests | 2,487 | 2,000 | 2,014 | — | ||||||||||
| Stockholders' equity | ||||||||||||||
| Preferred stock, $0.01 par value; 200,000 shares authorized | — | — | — | — | ||||||||||
| Common stock, $0.01 par value; 1,000,000 shares authorized | 3,808 | 3,808 | 3,806 | 3,806 | ||||||||||
| Additional paid-in capital | 9,595,033 | 9,591,194 | 9,587,637 | 9,586,556 | ||||||||||
| Accumulated other comprehensive income (loss) | 9,328 | (8,554) | 2,140 | 5,524 | ||||||||||
| Cumulative net income attributable to common stockholders | 1,137,171 | 1,219,930 | 1,307,055 | 1,342,819 | ||||||||||
Cumulative dividends 1 | (3,565,941) | (3,447,750) | (3,329,562) | (3,211,492) | ||||||||||
| Total stockholders' equity | 7,179,399 | 7,358,628 | 7,571,076 | 7,727,213 | ||||||||||
| Non-controlling interest | 104,018 | 106,211 | 108,742 | 111,813 | ||||||||||
| Total Equity | 7,283,417 | 7,464,839 | 7,679,818 | 7,839,026 | ||||||||||
| Total liabilities and stockholders' equity | $13,394,347 | $13,568,884 | $13,849,631 | $14,195,443 | ||||||||||
1Includes Legacy HTA's cumulative dividends in excess of earnings.
| HEALTHCARE REALTY TRUST INCORPORATED | HEALTHCAREREALTY.COM | PAGE 3 OF 6 | ||||
| Consolidated Statements of Income | ||
| DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA | ||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | |||||||||||||||||||||||||||||||||
| Revenues | |||||||||||||||||||||||||||||||||||
| Rental income | $329,680 | $324,093 | $329,399 | ||||||||||||||||||||||||||||||||
| Interest income | 4,233 | 4,214 | 4,227 | ||||||||||||||||||||||||||||||||
| Other operating | 4,230 | 4,618 | 4,436 | ||||||||||||||||||||||||||||||||
| 338,143 | 332,925 | 338,062 | |||||||||||||||||||||||||||||||||
| Expenses | |||||||||||||||||||||||||||||||||||
| Property operating | 125,395 | 122,040 | 117,009 | ||||||||||||||||||||||||||||||||
| General and administrative | 15,464 | 14,935 | 14,417 | ||||||||||||||||||||||||||||||||
Acquisition and pursuit costs 1 | 669 | 287 | 92 | ||||||||||||||||||||||||||||||||
| Merger-related costs | (15,670) | 4,855 | 10,777 | ||||||||||||||||||||||||||||||||
| Depreciation and amortization | 183,193 | 184,479 | 185,275 | ||||||||||||||||||||||||||||||||
| 309,051 | 326,596 | 327,570 | |||||||||||||||||||||||||||||||||
| Other income (expense) | |||||||||||||||||||||||||||||||||||
| Interest expense before merger-related fair value | (54,780) | (52,895) | (52,464) | ||||||||||||||||||||||||||||||||
| Merger-related fair value adjustment | (10,554) | (10,864) | (11,979) | ||||||||||||||||||||||||||||||||
| Interest expense | (65,334) | (63,759) | (64,443) | ||||||||||||||||||||||||||||||||
| Gain on sales of real estate properties | 7,156 | 1,007 | 73,083 | ||||||||||||||||||||||||||||||||
| Gain (loss) on extinguishment of debt | — | — | 119 | ||||||||||||||||||||||||||||||||
| Impairment of real estate assets and credit loss reserves | (55,215) | (31,422) | (54,452) | ||||||||||||||||||||||||||||||||
| Equity(loss) gain from unconsolidated joint ventures | (17) | (780) | 89 | ||||||||||||||||||||||||||||||||
| Interest and other income (expense), net | 592 | 547 | (1,168) | ||||||||||||||||||||||||||||||||
| (112,818) | (94,407) | (46,772) | |||||||||||||||||||||||||||||||||
| Net (loss) income | $(83,726) | $(88,078) | $(36,280) | ||||||||||||||||||||||||||||||||
| Net loss (income) attributable to non-controlling interests | 967 | 953 | 516 | ||||||||||||||||||||||||||||||||
| Net (loss) income attributable to common stockholders | $(82,759) | $(87,125) | $(35,764) | ||||||||||||||||||||||||||||||||
| Basic earnings per common share | $(0.22) | $(0.23) | $(0.10) | ||||||||||||||||||||||||||||||||
| Diluted earnings per common share | $(0.22) | $(0.23) | $(0.10) | ||||||||||||||||||||||||||||||||
| Weighted average common shares outstanding - basic | 378,897 | 378,840 | 378,617 | ||||||||||||||||||||||||||||||||
Weighted average common shares outstanding - diluted 2 | 378,897 | 378,840 | 378,617 | ||||||||||||||||||||||||||||||||
1Includes third party and travel costs related to the pursuit of acquisitions and developments.
2Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount. As a result, the Company's OP totaling 4,042,993 units was not included.
| HEALTHCARE REALTY TRUST INCORPORATED | HEALTHCAREREALTY.COM | PAGE 4 OF 6 | ||||
Reconciliation of FFO, Normalized FFO and FAD 1,2,3 | ||
| DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA | ||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net (loss) income attributable to common stockholders | $(82,759) | $(87,125) | $(35,764) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net (loss) income attributable to common stockholders per share 3 | $(0.22) | $(0.23) | $(0.10) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gain on sales of real estate assets | (7,156) | (1,007) | (73,083) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Impairments of real estate assets | 55,215 | 26,227 | 54,452 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real estate depreciation and amortization | 185,003 | 186,109 | 186,658 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-controlling (loss) income from partnership units | (1,027) | (1,067) | (382) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Unconsolidated JV depreciation and amortization | 4,412 | 4,841 | 4,020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FFO adjustments | $236,447 | $215,103 | $171,665 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FFO adjustments per common share - diluted | $0.62 | $0.56 | $0.45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FFO | $153,688 | $127,978 | $135,901 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FFO per common share - diluted | $0.40 | $0.33 | $0.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and pursuit costs | 669 | 287 | 92 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Merger-related costs | (15,670) | 4,855 | 10,777 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lease intangible amortization | 240 | 146 | 137 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-routine legal costs/forfeited earnest money received | 275 | — | 194 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt financing costs | — | — | 625 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Allowance for credit losses 4 | — | 8,599 | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Merger-related fair value adjustment | 10,554 | 10,864 | 11,979 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unconsolidated JV normalizing items 5 | 93 | 117 | 96 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Normalized FFO adjustments | $(3,839) | $24,868 | $23,900 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Normalized FFO adjustments per common share - diluted | $(0.01) | $0.06 | $0.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normalized FFO | $149,849 | $152,846 | $159,801 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Normalized FFO per common share - diluted | $0.39 | $0.40 | $0.42 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-real estate depreciation and amortization | 802 | 604 | 624 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Non-cash interest amortization, net 6 | 1,618 | 682 | 2,284 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rent reserves, net | (54) | 1,371 | (100) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Straight-line rent income, net | (8,005) | (8,246) | (9,873) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | 3,924 | 3,745 | 3,573 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unconsolidated JV non-cash items 7 | (316) | (227) | (316) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normalized FFO adjusted for non-cash items | 147,818 | 150,775 | 155,993 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2nd generation TI | (17,236) | (8,882) | (13,523) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leasing commissions paid | (5,493) | (7,013) | (7,404) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Capital expenditures | (8,649) | (8,946) | (25,669) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total maintenance capex | (31,378) | (24,841) | (46,596) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FAD | $116,440 | $125,934 | $109,397 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Quarterly dividends | $119,444 | $119,442 | $119,323 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FFO wtd avg common shares outstanding - diluted 8 | 383,409 | 383,335 | 383,228 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by NAREIT. NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.”
2FFO, Normalized FFO and Funds Available for Distribution ("FAD") do not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company's operating performance or as alternatives to cash flow as measures of liquidity.
3Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount.
4 In Q1 2023, allowance for credit losses included a $5.2 million credit allowance for a mezzanine loan included in "Impairment of real estate and credit loss reserves" on the Statement of Income and $3.4 million reserve included in “Rental Income” on the Statement of Income for previously deferred rent and straight line rent for three skilled nursing facilities.
5Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.
6Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.
7Includes the Company's proportionate share of straight-line rent, net and rent reserves, net related to unconsolidated joint ventures.
8The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstanding of 442,263 for the three months ended June 30, 2023. Also includes the diluted impact of 4,042,993 OP units outstanding.
| HEALTHCARE REALTY TRUST INCORPORATED | HEALTHCAREREALTY.COM | PAGE 5 OF 6 | ||||
| Reconciliation of Non-GAAP Measures | ||
| DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA - UNAUDITED | ||
Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors.
The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.
FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.” The Company defines Normalized FFO as FFO excluding acquisition-related expenses, lease intangible amortization and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, share-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company’s operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.
Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.
Merger Combined Cash NOI and Merger Combined Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Merger Combined Cash NOI as rental income and less property operating expenses. Merger Combined Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, tenant improvement amortization and leasing commission amortization. Merger Combined Cash NOI is historical and not necessarily indicative of future results.
Merger Combined Same Store Cash NOI compares Merger Combined Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.
The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures. These properties are described in additional detail in Footnote 6 to the Condensed Consolidated Financial Statements.
Any recently acquired property will be included in the same store pool once the Company has owned the property for eight full quarters. Newly developed or redeveloped properties will be included in the same store pool eight full quarters after substantial completion.
| HEALTHCARE REALTY TRUST INCORPORATED | HEALTHCAREREALTY.COM | PAGE 6 OF 6 | ||||
2Q2023 | ||
| Supplemental Information | ||
| FURNISHED AS OF AUGUST 8, 2023 - UNAUDITED | ||
 | ||
| FORWARD LOOKING STATEMENTS & RISK FACTORS | ||
This Supplemental Information report contains disclosures that are “forward-looking statements” as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words and phrases such as “can,” “may,” “payable,” “indicative,” "predictive," “annualized,” “expect,” “expected,” “range of expectations,” "would have been," "budget," and other comparable terms in this report, and include, but are not limited to, statements related to the merger between Healthcare Realty Trust Incorporated (“Legacy HR” and, after the closing of the merger, the “Company” or "HR") and Healthcare Trust of America, Inc. (“HTA”) that closed on July 20, 2022 (the “Merger”). These forward-looking statements are made as of the date of this report and are not necessarily indicative of future performance. These statements are based on the current plans and expectations of Company management and are subject to a number of unknown risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those described in this release or implied by such forward-looking statements. Such risks and uncertainties include, among other things, the following: failure to realize the expected benefits of the Merger; the risk that the Company’s and HTA’s respective businesses will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline; pandemics or other health crises, such as COVID-19; increases in interest rates; the availability and cost of capital at expected rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to release space at similar rates as vacancies occur; the Company's ability to renew expiring leases; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; the Company may be required under purchase options to sell properties and may not be able to reinvest the proceeds from such sales at rates of return equal to the return received on the properties sold; uninsured or underinsured losses related to casualty or liability; the incurrence of impairment charges on its real estate properties or other assets; and other legal and operational matters. Other risks, uncertainties and factors that could cause actual results to differ materially from those projected are detailed under the heading “Risk Factors,” in the Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) for the year ended December 31, 2022, under the heading "Risk Factors" and other risks described from time to time thereafter in the Company's SEC filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
| Table of Contents | ||
| Highlights | |||||
| Salient Facts | |||||
| Corporate Information | |||||
| Balance Sheet | |||||
| Statements of Income | |||||
| FFO, Normalized FFO, & FAD | |||||
| Capital Funding & Commitments | |||||
| Debt Metrics | |||||
| Debt Covenants & Liquidity | |||||
| Investment Activity | |||||
| Re/development Activity | |||||
| Portfolio | |||||
| Health Systems | |||||
| MOB Proximity to Hospital | |||||
| Lease Maturity & Occupancy | |||||
| Leasing Statistics | |||||
| NOI Performance | |||||
| NOI Reconciliations | |||||
| 23 | EBITDA Reconciliations | ||||
| Components of Net Asset Value | |||||
| Components of Expected FFO | |||||
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 3 | ||||
| Highlights | ||
| QUARTERLY HIGHLIGHTS | ||
•Net loss attributable to common stockholders for the three months ended June 30, 2023 was $82.8 million or $0.22 per diluted common share.
•Normalized FFO per share totaled $0.39.
•The Company merged with Legacy HTA on July 20, 2022. Beginning in third quarter of 2022, the Company reported combined company same store results, which are now referred to as Merger Combined Same Store. Merger Combined Same Store includes the Company’s same store properties, including Legacy HTA properties, that were owned for the full comparative period, and that meet each other element of the Company’s same store criteria. The Company presents the combined companies’ same store portfolios to provide an understanding of the operating performance and growth potential of the combined company.
•Merger Combined Same Store cash NOI, including the Company's share of joint ventures, for the second quarter increased 2.1% over the prior year, and 2.9% for the trailing twelve months ended June 30, 2023.
•Predictive growth measures in the Merger Combined Same Store portfolio include:
◦Average in-place rent increases of 2.7%
◦Future annual contractual increases of 3.0% for leases commencing in the quarter.
◦Weighted average MOB cash leasing spreads of 3.0% on 598,000 square feet renewed:
▪6% (<0% spread)
▪16% (0-3%)
▪62% (3-4%)
▪15% (>4%)
◦Tenant retention of 80.5%
◦Year-over-year absorption of 26,000 square feet resulted in an average occupancy increase of 20 basis points, to 89.0%.
•Portfolio leasing activity that commenced in the second quarter totaled 1,041,000 square feet related to 306 leases:
◦736,000 square feet of renewals
◦305,000 square feet of new and expansion leases
•The Company executed new leases totaling 376,000 square feet in the quarter that will commence in future periods, an increase of 57% over the first quarter.
•The total portfolio leased percentage was 88.9% at June 30, which was 150 basis points greater than portfolio occupancy. The portfolio leased percentage increased 30 basis points from the first quarter.
•Since the end of the first quarter, the Company sold three properties totaling $21.6 million. The Company expects to generate over $300 million of proceeds related to properties under contract or letters of intent that are expected to be sold by year-end.
•Net debt to adjusted EBITDA was 6.6 times at the end of the quarter. Leverage is expected to decline from additional asset sales and underlying portfolio NOI growth.
•A dividend of $0.31 per share was paid in June. A dividend of $0.31 per share will be paid on August 30, 2023 to stockholders and OP unitholders of record on August 15, 2023.
•On Tuesday, August 8, 2023, at 11:00 a.m. Central Time, Healthcare Realty Trust has scheduled a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends. Simultaneously, a webcast of the conference call will be available to interested parties at https://investors.healthcarerealty.com/corporate-profile/webcasts under the Investor Relations section. A webcast replay will be available following the call at the same address. Conference Call Access Details: Domestic Dial-In Number: +1 833-470-1428 access code 294698; All Other Locations: +1 404-975-4839 access code 294698. Replay Information: Domestic Dial-In Number: +1 866-813-9403 access code 594252; All Other Locations: +1 929-458-6194 access code 594252.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 4 | ||||
Salient Facts 1 | ||
| AS OF JUNE 30, 2023 | ||
| Properties |  | ||||||||||
| 714 properties totaling 41.8M SF | |||||||||||
| 73 markets in 35 states | |||||||||||
| 93% managed by Healthcare Realty | |||||||||||
| 91% outpatient medical facilities | |||||||||||
| 60% of NOI in Top 15 Markets | |||||||||||
| Capitalization | |||||||||||
| $12.9B enterprise value as of 6/30/23 | |||||||||||
| $7.3B market capitalization as of 6/30/23 | |||||||||||
| 384.9M shares outstanding (including OP units) | |||||||||||
| $0.31 quarterly dividend per share | |||||||||||
| BBB/Baa2 S&P/Moody's | |||||||||||
| 43.6% net debt to enterprise value at 6/30/23 | |||||||||||
| 6.6x net debt to adjusted EBITDA | |||||||||||
1 Includes properties held in joint ventures.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 5 | ||||
| Corporate Information | ||
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June 30, 2023, the Company was invested in 714 real estate properties in 35 states totaling 41.8 million square feet and had an enterprise value of approximately $12.9 billion, defined as equity market capitalization plus the principal amount of debt less cash. The Company provided leasing and property management services to 93% of its portfolio.
| EXECUTIVE OFFICERS | ||
| Todd J. Meredith | ||
| President and Chief Executive Officer | ||
| John M. Bryant, Jr. | ||
| Executive Vice President and General Counsel | ||
| J. Christopher Douglas | ||
| Executive Vice President and Chief Financial Officer | ||
| Robert E. Hull | ||
| Executive Vice President - Investments | ||
| Julie F. Wilson | ||
| Executive Vice President - Operations | ||
| ANALYST COVERAGE | |||||
| Barclays Research | |||||
| BMO Capital Markets | |||||
| BTIG, LLC | |||||
| Citi Research | |||||
| Green Street Advisors, Inc. | |||||
| J.P. Morgan Securities LLC | |||||
| Jefferies LLC | |||||
| KeyBanc Capital Markets Inc. | |||||
| Raymond James & Associates | |||||
| Scotiabank | |||||
| Stifel, Nicolaus & Company, Inc. | |||||
| Wells Fargo Securities, LLC | |||||
| BOARD OF DIRECTORS | |||||
J. Knox Singleton
Chairman, Healthcare Realty Trust Incorporated
Retired Chief Executive Officer, Inova Health System
W. Bradley Blair, II
Vice Chairman, Healthcare Realty Trust Incorporated
Retired Chairman, Healthcare Trust of America
Todd J. Meredith
President and Chief Executive Officer
Healthcare Realty Trust Incorporated
John V. Abbott
Retired Chief Executive Officer
Aviation Asset Management Group, General Electric Company
Nancy H. Agee
President and Chief Executive Officer
Carilion Clinic
Vicki U. Booth
President and Board Chair
Ueberroth Family Foundation
Edward H. Braman
Retired Audit Partner
Ernst & Young LLP
Ajay Gupta
Chief Executive Officer
Physician Rehabilitation Network
James J. Kilroy
President and Portfolio Manager
Willis Investment Counsel
Jay P. Leupp
Managing Partner and Senior Portfolio Manager
Terra Firma Asset Management, LLC
Peter F. Lyle
Executive Vice President
Medical Management Associates, Inc.
Constance B. Moore
Retired President and CEO
BRE Properties, Inc.
Christann M. Vasquez
Retired Executive Vice President and Chief Operating Officer
Ascension Texas
David R. Emery (1944-2019)
Chairman Emeritus
Healthcare Realty Trust Incorporated
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 6 | ||||
| Balance Sheet | ||
| AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA | ||
| ASSETS | |||||||||||||||||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | 3Q 2022 | ||||||||||||||
| Real estate properties | |||||||||||||||||
| Land | $1,424,453 | $1,412,805 | $1,439,798 | $1,449,550 | |||||||||||||
| Buildings and improvements | 11,188,821 | 11,196,297 | 11,332,037 | 11,439,797 | |||||||||||||
| Lease intangibles | 922,029 | 929,008 | 959,998 | 968,914 | |||||||||||||
| Personal property | 12,615 | 11,945 | 11,907 | 11,680 | |||||||||||||
| Investment in financing receivables, net | 121,315 | 120,692 | 120,236 | 118,919 | |||||||||||||
| Financing lease right-of-use assets | 83,016 | 83,420 | 83,824 | 79,950 | |||||||||||||
| Construction in progress | 53,311 | 42,615 | 35,560 | 43,148 | |||||||||||||
| Land held for development | 78,411 | 69,575 | 74,265 | 73,321 | |||||||||||||
| Total real estate investments | 13,883,971 | 13,866,357 | 14,057,625 | 14,185,279 | |||||||||||||
| Less accumulated depreciation and amortization | (1,983,944) | (1,810,093) | (1,645,271) | (1,468,736) | |||||||||||||
| Total real estate investments, net | 11,900,027 | 12,056,264 | 12,412,354 | 12,716,543 | |||||||||||||
| Cash and cash equivalents | 35,904 | 49,941 | 60,961 | 57,583 | |||||||||||||
| Assets held for sale, net | 151 | 3,579 | 18,893 | 185,074 | |||||||||||||
| Operating lease right-of-use assets | 333,224 | 336,112 | 336,983 | 321,365 | |||||||||||||
| Investments in unconsolidated joint ventures | 327,245 | 327,746 | 327,248 | 327,752 | |||||||||||||
| Other assets, net and goodwill | 797,796 | 795,242 | 693,192 | 587,126 | |||||||||||||
| Total assets | $13,394,347 | $13,568,884 | $13,849,631 | $14,195,443 | |||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||||||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | 3Q 2022 | ||||||||||||||
| Liabilities | |||||||||||||||||
| Notes and bonds payable | $5,340,272 | $5,361,699 | $5,351,827 | $5,570,139 | |||||||||||||
| Accounts payable and accrued liabilities | 196,147 | 155,210 | 244,033 | 231,018 | |||||||||||||
| Liabilities of properties held for sale | 222 | 277 | 437 | 10,644 | |||||||||||||
| Operating lease liabilities | 278,479 | 279,637 | 279,895 | 268,840 | |||||||||||||
| Financing lease liabilities | 73,629 | 73,193 | 72,939 | 72,378 | |||||||||||||
| Other liabilities | 219,694 | 232,029 | 218,668 | 203,398 | |||||||||||||
| Total liabilities | 6,108,443 | 6,102,045 | 6,167,799 | 6,356,417 | |||||||||||||
| Redeemable non-controlling interests | 2,487 | 2,000 | 2,014 | — | |||||||||||||
| Stockholders' equity | |||||||||||||||||
| Preferred stock, $0.01 par value; 200,000 shares authorized | — | — | — | — | |||||||||||||
| Common stock, $0.01 par value; 1,000,000 shares authorized | 3,808 | 3,808 | 3,806 | 3,806 | |||||||||||||
| Additional paid-in capital | 9,595,033 | 9,591,194 | 9,587,637 | 9,586,556 | |||||||||||||
| Accumulated other comprehensive (loss) income | 9,328 | (8,554) | 2,140 | 5,524 | |||||||||||||
| Cumulative net income attributable to common stockholders | 1,137,171 | 1,219,930 | 1,307,055 | 1,342,819 | |||||||||||||
| Cumulative dividends | (3,565,941) | (3,447,750) | (3,329,562) | (3,211,492) | |||||||||||||
| Total stockholders' equity | 7,179,399 | 7,358,628 | 7,571,076 | 7,727,213 | |||||||||||||
| Non-controlling interest | 104,018 | 106,211 | 108,742 | 111,813 | |||||||||||||
| Total equity | 7,283,417 | 7,464,839 | 7,679,818 | 7,839,026 | |||||||||||||
| Total liabilities and stockholders' equity | $13,394,347 | $13,568,884 | $13,849,631 | $14,195,443 | |||||||||||||
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 7 | ||||
| Statements of Income | ||
| DOLLARS IN THOUSANDS | ||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | ||||||||||||||||||||||||||||||||||||||||||
| Revenues | ||||||||||||||||||||||||||||||||||||||||||||
| Rental income | $329,680 | $324,093 | $329,399 | |||||||||||||||||||||||||||||||||||||||||
| Interest income | 4,233 | 4,214 | 4,227 | |||||||||||||||||||||||||||||||||||||||||
| Other operating | 4,230 | 4,618 | 4,436 | |||||||||||||||||||||||||||||||||||||||||
| 338,143 | 332,925 | 338,062 | ||||||||||||||||||||||||||||||||||||||||||
| Expenses | ||||||||||||||||||||||||||||||||||||||||||||
| Property operating | 125,395 | 122,040 | 117,009 | |||||||||||||||||||||||||||||||||||||||||
| General and administrative | 15,464 | 14,935 | 14,417 | |||||||||||||||||||||||||||||||||||||||||
Acquisition and pursuit costs 1 | 669 | 287 | 92 | |||||||||||||||||||||||||||||||||||||||||
| Merger-related costs | (15,670) | 4,855 | 10,777 | |||||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | 183,193 | 184,479 | 185,275 | |||||||||||||||||||||||||||||||||||||||||
| 309,051 | 326,596 | 327,570 | ||||||||||||||||||||||||||||||||||||||||||
| Other income (expense) | ||||||||||||||||||||||||||||||||||||||||||||
| Interest expense before merger-related fair value | (54,780) | (52,895) | (52,464) | |||||||||||||||||||||||||||||||||||||||||
| Merger-related fair value adjustment | (10,554) | (10,864) | (11,979) | |||||||||||||||||||||||||||||||||||||||||
| Interest expense | (65,334) | (63,759) | (64,443) | |||||||||||||||||||||||||||||||||||||||||
| Gain on sales of real estate properties | 7,156 | 1,007 | 73,083 | |||||||||||||||||||||||||||||||||||||||||
| Gain on extinguishment of debt | — | — | 119 | |||||||||||||||||||||||||||||||||||||||||
| Impairment of real estate assets and credit loss reserves | (55,215) | (31,422) | (54,452) | |||||||||||||||||||||||||||||||||||||||||
| Equity (loss) gain from unconsolidated joint ventures | (17) | (780) | 89 | |||||||||||||||||||||||||||||||||||||||||
| Interest and other income (expense), net | 592 | 547 | (1,168) | |||||||||||||||||||||||||||||||||||||||||
| (112,818) | (94,407) | (46,772) | ||||||||||||||||||||||||||||||||||||||||||
| Net loss | $(83,726) | $(88,078) | $(36,280) | |||||||||||||||||||||||||||||||||||||||||
| Net loss attributable to non-controlling interests | 967 | 953 | 516 | |||||||||||||||||||||||||||||||||||||||||
| Net loss attributable to common stockholders | $(82,759) | $(87,125) | $(35,764) | |||||||||||||||||||||||||||||||||||||||||
| Basic earnings per common share | $(0.22) | $(0.23) | $(0.10) | |||||||||||||||||||||||||||||||||||||||||
| Diluted earnings per common share | $(0.22) | $(0.23) | $(0.10) | |||||||||||||||||||||||||||||||||||||||||
| Weighted average common shares outstanding - basic | 378,897 | 378,840 | 378,617 | |||||||||||||||||||||||||||||||||||||||||
Weighted average common shares outstanding - diluted 2 | 378,897 | 378,840 | 378,617 | |||||||||||||||||||||||||||||||||||||||||
| STATEMENTS OF INCOME SUPPLEMENTAL INFORMATION | ||||||||||||||||||||||||||||||||||||||||||||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | ||||||||||||||||||||||||||||||||||||||||||
| Interest income | ||||||||||||||||||||||||||||||||||||||||||||
| Financing receivables | $2,053 | $2,144 | $2,203 | |||||||||||||||||||||||||||||||||||||||||
| Interest on mortgage and mezzanine loans | 2,180 | 2,070 | 2,024 | |||||||||||||||||||||||||||||||||||||||||
| Total | $4,233 | $4,214 | $4,227 | |||||||||||||||||||||||||||||||||||||||||
| Other operating income | ||||||||||||||||||||||||||||||||||||||||||||
| Parking income | $2,370 | $2,391 | $2,413 | |||||||||||||||||||||||||||||||||||||||||
| Management fee income | 1,597 | 1,973 | 1,803 | |||||||||||||||||||||||||||||||||||||||||
| Miscellaneous | 263 | 254 | 220 | |||||||||||||||||||||||||||||||||||||||||
| Total | $4,230 | $4,618 | $4,436 | |||||||||||||||||||||||||||||||||||||||||
1Includes third party and travel costs related to the pursuit of acquisitions and developments.
2Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount. As a result, the Company's OP totaling 4,042,993 units was not included.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 8 | ||||
FFO, Normalized FFO, & FAD 1,2,3 | ||
| DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA | ||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net loss attributable to common stockholders | $(82,759) | $(87,125) | $(35,764) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Net loss attributable to common stockholders per share 3 | $(0.22) | $(0.23) | $(0.10) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gain on sales of real estate assets | $(7,156) | $(1,007) | (73,083) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Impairments of real estate assets | 55,215 | 26,227 | 54,452 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real estate depreciation and amortization | 185,003 | 186,109 | 186,658 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-controlling (loss) income from partnership units | (1,027) | (1,067) | (382) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Unconsolidated JV depreciation and amortization | 4,412 | 4,841 | 4,020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| FFO adjustments | $236,447 | $215,103 | $171,665 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| FFO adjustments per common share - diluted | $0.62 | $0.56 | $0.45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| FFO | $153,688 | $127,978 | $135,901 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| FFO per common share - diluted | $0.40 | $0.33 | $0.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and pursuit costs | 669 | 287 | 92 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Merger-related costs | (15,670) | 4,855 | 10,777 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lease intangible amortization | 240 | 146 | 137 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-routine legal costs/forfeited earnest money received | 275 | — | 194 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt financing costs | — | — | 625 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Allowance for credit losses 4 | — | 8,599 | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Merger-related fair value adjustment | 10,554 | 10,864 | 11,979 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Unconsolidated JV normalizing items 5 | 93 | 117 | 96 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Normalized FFO adjustments | $(3,839) | $24,868 | $23,900 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Normalized FFO adjustments per common share - diluted | $(0.01) | $0.06 | $0.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Normalized FFO | $149,849 | $152,846 | $159,801 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Normalized FFO per common share - diluted | $0.39 | $0.40 | $0.42 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-real estate depreciation and amortization | 802 | 604 | 624 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Non-cash interest amortization, net 6 | 1,618 | 682 | 2,284 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rent reserves, net | (54) | 1,371 | (100) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Straight-line rent income, net | (8,005) | (8,246) | (9,873) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | 3,924 | 3,745 | 3,573 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Unconsolidated JV non-cash items 7 | (316) | (227) | (316) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Normalized FFO adjusted for non-cash items | 147,818 | 150,775 | 155,993 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2nd generation TI | (17,236) | (8,882) | (13,523) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leasing commissions paid | (5,493) | (7,013) | (7,404) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Capital expenditures | (8,649) | (8,946) | (25,669) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total maintenance capex | (31,378) | (24,841) | (46,596) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| FAD | $116,440 | $125,934 | $109,397 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Quarterly dividends and OP distributions | $119,444 | $119,442 | $119,323 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
FFO wtd avg common shares outstanding - diluted 8 | 383,409 | 383,335 | 383,228 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
1Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by NAREIT. NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.”
2FFO, Normalized FFO and Funds Available for Distribution ("FAD") do not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company's operating performance or as alternatives to cash flow as measures of liquidity.
3Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount.
4 In Q1 2023, allowance for credit losses included a $5.2 million credit allowance for a mezzanine loan included in "Impairment of real estate and credit loss reserves" on the Statement of Income and $3.4 million reserve included in “Rental Income” on the Statement of Income for previously deferred rent and straight line rent for three skilled nursing facilities.
5Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.
6Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.
7Includes the Company's proportionate share of straight-line rent, net and rent reserves, net related to unconsolidated joint ventures.
8The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstanding of 442,263 for the three months ended June 30, 2023. Also includes the diluted impact of 4,042,993 OP units outstanding.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 9 | ||||
Capital Funding & Commitments 1 | ||
| DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA | ||
| ACQUISITION AND RE/DEVELOPMENT FUNDING | |||||||||||||||||||||||||||||||||||||||||
| Post-merger | Pre-merger | ||||||||||||||||||||||||||||||||||||||||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | 3Q 2022 | 2Q 2022 | |||||||||||||||||||||||||||||||||||||
Acquisitions 2 | $— | $31,500 | $26,388 | $91,253 | $163,762 | ||||||||||||||||||||||||||||||||||||
| Re/development | 32,068 | 16,928 | 23,372 | 31,546 | 9,387 | ||||||||||||||||||||||||||||||||||||
1st generation TI & acquisition capex 3 | 10,258 | 11,870 | 21,218 | 12,596 | 8,103 | ||||||||||||||||||||||||||||||||||||
| MAINTENANCE CAPITAL EXPENDITURES FUNDING | |||||||||||||||||||||||||||||||||||||||||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | 3Q 2022 | 2Q 2022 | |||||||||||||||||||||||||||||||||||||
| 2nd generation TI | $17,236 | $8,882 | $13,523 | $11,763 | $5,051 | ||||||||||||||||||||||||||||||||||||
| Leasing commissions paid | 5,493 | 7,013 | 7,404 | 8,739 | 3,475 | ||||||||||||||||||||||||||||||||||||
| Capital expenditures | 8,649 | 8,946 | 25,669 | 17,461 | 4,557 | ||||||||||||||||||||||||||||||||||||
| $31,378 | $24,841 | $46,596 | $37,963 | $13,083 | |||||||||||||||||||||||||||||||||||||
| % of Cash NOI | |||||||||||||||||||||||||||||||||||||||||
| 2nd generation TI | 8.3 | % | 4.2 | % | 6.4 | % | 5.5 | % | 5.6 | % | |||||||||||||||||||||||||||||||
| Leasing commissions paid | 2.6 | % | 3.3 | % | 3.5 | % | 4.1 | % | 3.9 | % | |||||||||||||||||||||||||||||||
| Capital expenditures | 4.2 | % | 4.3 | % | 12.1 | % | 8.1 | % | 5.1 | % | |||||||||||||||||||||||||||||||
| 15.1 | % | 11.8 | % | 22.0 | % | 17.7 | % | 14.6 | % | ||||||||||||||||||||||||||||||||
LEASING COMMITMENTS 4 | |||||||||||||||||||||||||||||||||||||||||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | 3Q 2022 | 2Q 2022 | |||||||||||||||||||||||||||||||||||||
| Renewals | |||||||||||||||||||||||||||||||||||||||||
| Square feet | 638,587 | 949,285 | 623,363 | 632,690 | 205,400 | ||||||||||||||||||||||||||||||||||||
| 2nd generation TI/square foot/lease year | $1.64 | $1.84 | $1.90 | $1.66 | $1.66 | ||||||||||||||||||||||||||||||||||||
| Leasing commissions/square foot/lease year | $1.19 | $0.87 | $0.78 | $1.03 | $1.15 | ||||||||||||||||||||||||||||||||||||
| Renewal commitments as a % of annual net rent | 12.8 | % | 11.5 | % | 11.7 | % | 10.5 | % | 11.4 | % | |||||||||||||||||||||||||||||||
WALT (in months) 5 | 56.7 | 56.8 | 51.7 | 50.1 | 39.7 | ||||||||||||||||||||||||||||||||||||
| New leases | |||||||||||||||||||||||||||||||||||||||||
| Square feet | 205,565 | 274,344 | 297,340 | 262,904 | 79,467 | ||||||||||||||||||||||||||||||||||||
| 2nd generation TI/square foot/lease year | $7.11 | $4.44 | $6.25 | $4.84 | $7.07 | ||||||||||||||||||||||||||||||||||||
| Leasing commissions/square foot/lease year | $1.40 | $0.83 | $1.49 | $1.39 | $1.65 | ||||||||||||||||||||||||||||||||||||
| New lease commitments as a % of annual net rent | 45.0 | % | 21.6 | % | 36.2 | % | 28.1 | % | 40.6 | % | |||||||||||||||||||||||||||||||
WALT (in months) 5 | 81.3 | 84.7 | 72.7 | 87.1 | 77.4 | ||||||||||||||||||||||||||||||||||||
| All | |||||||||||||||||||||||||||||||||||||||||
| Square feet | 844,152 | 1,223,629 | 920,703 | 895,594 | 284,867 | ||||||||||||||||||||||||||||||||||||
| Leasing commitments as a % of annual net rent | 21.7 | % | 14.7 | % | 21.0 | % | 16.9 | % | 22.6 | % | |||||||||||||||||||||||||||||||
WALT (in months) 5 | 62.7 | 63.1 | 58.4 | 61.0 | 50.2 | ||||||||||||||||||||||||||||||||||||
1On July 20, 2022, Legacy HR and HTA closed the merger of the two companies, in which Legacy HR was the acquirer under GAAP. Accordingly, the historic financial statements of the combined company are those of Legacy HR.
2Acquisitions include properties acquired through joint ventures at the Company's ownership percentage.
3Acquisition capex includes near-term fundings underwritten as part of recent acquisitions.
4Excludes recently acquired or disposed properties, development completions, construction in progress, land held for development, corporate property, redevelopment properties, planned dispositions and assets classified as held for sale.
5WALT = weighted average lease term.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 10 | ||||
Debt Metrics1 | ||
| DOLLARS IN THOUSANDS | ||
| SUMMARY OF INDEBTEDNESS AS OF JUNE 30, 2023 | |||||||||||||||||||||||||||||
| PRINCIPAL BALANCE | BALANCE 1 | MATURITY DATE | MONTHS TO MATURITY 2 | INTEREST EXPENSE | CONTRACTUAL INTEREST EXPENSE | CONTRACTUAL RATE | EFFECTIVE RATE | FAIR VALUE MERGER ADJUSTED | |||||||||||||||||||||
| SENIOR NOTES | $250,000 | $249,298 | 5/1/2025 | 22 | $2,470 | $2,422 | 3.88 | % | 4.12 | % | |||||||||||||||||||
| 600,000 | 575,256 | 8/1/2026 | 37 | 7,096 | 5,250 | 3.50 | % | 4.94 | % | Y | |||||||||||||||||||
| 500,000 | 481,615 | 7/1/2027 | 48 | 5,725 | 4,687 | 3.75 | % | 4.76 | % | Y | |||||||||||||||||||
| 300,000 | 297,138 | 1/15/2028 | 55 | 2,782 | 2,719 | 3.63 | % | 3.85 | % | ||||||||||||||||||||
| 650,000 | 570,356 | 2/15/2030 | 80 | 7,531 | 5,037 | 3.10 | % | 5.30 | % | Y | |||||||||||||||||||
| 299,500 | 296,579 | 3/15/2030 | 81 | 1,927 | 1,797 | 2.40 | % | 2.72 | % | ||||||||||||||||||||
| 300,000 | 295,795 | 3/15/2031 | 93 | 1,592 | 1,538 | 2.05 | % | 2.25 | % | ||||||||||||||||||||
| 800,000 | 640,999 | 3/15/2031 | 93 | 8,180 | 4,000 | 2.00 | % | 5.13 | % | Y | |||||||||||||||||||
| $3,699,500 | $3,407,036 | 65 | $37,303 | $27,450 | 2.97 | % | 4.43 | % | |||||||||||||||||||||
| TERM LOANS | $350,000 | $349,499 | 7/20/2025 | 25 | $5,337 | $5,337 | SOFR + 1.05% | 6.21 | % | ||||||||||||||||||||
| 200,000 | 199,786 | 5/31/2026 | 35 | 3,050 | 3,050 | SOFR + 1.05% | 6.21 | % | |||||||||||||||||||||
| 150,000 | 149,569 | 6/1/2026 | 35 | 2,287 | 2,287 | SOFR + 1.05% | 6.21 | % | |||||||||||||||||||||
| 300,000 | 299,947 | 10/31/2026 | 40 | 4,575 | 4,575 | SOFR + 1.05% | 6.21 | % | |||||||||||||||||||||
| 200,000 | 199,432 | 7/1/2027 | 48 | 3,050 | 3,050 | SOFR + 1.05% | 6.21 | % | |||||||||||||||||||||
| 300,000 | 298,079 | 1/12/2028 | 54 | 4,575 | 4,575 | SOFR + 1.05% | 6.21 | % | |||||||||||||||||||||
| $1,500,000 | $1,496,312 | 39 | $22,874 | $22,874 | 6.21 | % | |||||||||||||||||||||||
| $1.5B CREDIT FACILITY | $354,000 | $354,000 | 10/31/2027 | 52 | $5,235 | $5,235 | SOFR + 0.95% | 6.05 | % | ||||||||||||||||||||
| MORTGAGES | $82,783 | $82,924 | various | 20 | $791 | $846 | 4.07 | % | 4.00 | % | |||||||||||||||||||
| $5,636,283 | $5,340,272 | 54 | $66,203 | $56,405 | 4.04 | % | 5.03 | % | $2,550,000 | ||||||||||||||||||||
| Interest rate swaps | (4,566) | (4,566) | |||||||||||||||||||||||||||
| Interest cost capitalization | (712) | — | |||||||||||||||||||||||||||
| Unsecured credit facility fee & deferred financing costs | 2,489 | 927 | |||||||||||||||||||||||||||
| Amortization of fair value of January 2024 swap | 997 | — | 1.21 | % | 3.21 | % | Y | ||||||||||||||||||||||
| Financing right-of-use asset amortization | 923 | — | |||||||||||||||||||||||||||
| $65,334 | $52,766 | ||||||||||||||||||||||||||||
| DEBT MATURITIES SCHEDULE AS OF JUNE 30, 2023 | |||||||||||||||||||||||
| PRINCIPAL PAYMENTS | |||||||||||||||||||||||
| BANK LOANS | SENIOR NOTES | MORTGAGE NOTES | TOTAL | WA RATE | |||||||||||||||||||
| 2023 | $17,540 | $17,540 | 3.81 | % | |||||||||||||||||||
| 2024 | 25,353 | 25,353 | 4.41 | % | |||||||||||||||||||
| 2025 | $350,000 | $250,000 | 16,250 | 616,250 | 5.21 | % | |||||||||||||||||
| 2026 | 650,000 | 600,000 | 23,640 | 1,273,640 | 4.89 | % | |||||||||||||||||
| 2027 | 554,000 | 500,000 | 1,054,000 | 4.99 | % | ||||||||||||||||||
| 2028 | 300,000 | 300,000 | 600,000 | 4.92 | % | ||||||||||||||||||
| Thereafter | 2,049,500 | 2,049,500 | 2.41 | % | |||||||||||||||||||
| Total | $1,854,000 | $3,699,500 | $82,783 | $5,636,283 | 4.04 | % | |||||||||||||||||
Fixed rate debt balance 3 | $1,000,000 | $3,699,500 | $82,783 | $4,782,283 | |||||||||||||||||||
% fixed rate debt to net debt | 85.6 | % | |||||||||||||||||||||
Company share of JV debt | $27,640 | ||||||||||||||||||||||
| INTEREST RATE SWAPS | ||||||||
| MATURITY | AMOUNT | FIXED SOFR RATE | ||||||
| January 2024 | 200,000 | 1.21 | % | |||||
| May 2026 | 100,000 | 2.15 | % | |||||
| June 2026 | 150,000 | 3.83 | % | |||||
| December 2026 | 150,000 | 3.84 | % | |||||
| June 2027 | 150,000 | 4.13 | % | |||||
| December 2027 | 250,000 | 3.79 | % | |||||
| As of 6/30/2023 | $ | 1,000,000 | 3.17 | % | ||||
1Balances are reflected net of discounts, fair value adjustments, and deferred financing costs and include premiums.
2Includes extension options.
3Reflects $1.0 billion of interest rate swaps.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 11 | ||||
Debt Covenants & Liquidity1 | ||
| DOLLARS IN THOUSANDS | ||
SELECTED FINANCIAL DEBT COVENANTS YEAR ENDED JUNE 30, 2023 2 | |||||||||||
| CALCULATION | REQUIREMENT | PER DEBT COVENANTS | |||||||||
| Revolving credit facility and term loan | |||||||||||
| Leverage ratio | Total debt/total capital | Not greater than 60% | 38.7 | % | |||||||
| Secured leverage ratio | Total secured debt/total capital | Not greater than 30% | 0.6 | % | |||||||
| Unencumbered leverage ratio | Unsecured debt/unsecured real estate | Not greater than 60% | 39.8 | % | |||||||
| Fixed charge coverage ratio | EBITDA/fixed charges | Not less than 1.50x | 3.2x | ||||||||
| Unsecured coverage ratio | Unsecured EBITDA/unsecured interest | Not less than 1.75x | 3.2x | ||||||||
| Asset investments | Unimproved land, JVs & mortgages/total assets | Not greater than 35% | 8.3 | % | |||||||
| Senior Notes | |||||||||||
| Incurrence of total debt | Total debt/total assets | Not greater than 60% | 38.6 | % | |||||||
| Incurrence of debt secured by any lien | Secured debt/total assets | Not greater than 40% | 0.6 | % | |||||||
| Maintenance of total unsecured assets | Unencumbered assets/unsecured debt | Not less than 150% | 256.1 | % | |||||||
| Debt service coverage | EBITDA/interest expense | Not less than 1.5x | 3.0x | ||||||||
| Other | |||||||||||
Net debt to adjusted EBITDA 3 | Net debt (debt less cash)/adjusted EBITDA | Not required | 6.6x | ||||||||
Net debt to enterprise value 4 | Net debt/enterprise value | Not required | 43.6 | % | |||||||
| LIQUIDITY SOURCES | |||||
| Cash | $35,904 | ||||
| Unsecured credit facility availability | 1,146,000 | ||||
Consolidated unencumbered assets (gross) 5 | 13,657,311 | ||||
1On July 20, 2022, Legacy HR and HTA closed the merger of the two companies, in which Legacy HR was the acquirer under GAAP. Accordingly, the historic financial statements of the combined company are those of Legacy HR.
2Does not include all financial and non-financial covenants and restrictions that are required by the Company's various debt agreements. Financial measures include the Company's proportionate share of unconsolidated joint ventures, as applicable.
3See page 23 for a reconciliation of adjusted EBITDA.
4Based on the closing price of $18.86 on June 30, 2023 and 384,900,525 shares outstanding including outstanding OP units.
5Annualized first quarter 2023 unencumbered asset NOI was $794.9 million.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 12 | ||||
| Investment Activity | ||
| DOLLARS IN THOUSANDS | ||
| MOB ACQUISITION ACTIVITY | |||||||||||||||||||||||||||||
| MARKET | COUNT | MILES TO CAMPUS | ASSOCIATED HEALTH SYSTEM | CLOSING | SQUARE FEET | LEASED % | PURCHASE PRICE 1 | % OWNERSHIP | |||||||||||||||||||||
| Tampa, FL | 1 | 0.06 | BayCare Health | 3/10/2023 | 115,867 | 98 | % | $31,500 | 100 | % | |||||||||||||||||||
| Colorado Springs, CO | 1 | 1.30 | UC Health | 7/28/2023 | 42,770 | 94 | % | 11,450 | 100 | % | |||||||||||||||||||
| YTD total | 2 | 158,637 | 97 | % | $42,950 | 100 | % | ||||||||||||||||||||||
YTD average cap rate 2 | 6.5 | % | |||||||||||||||||||||||||||
| DISPOSITIONS TO REPAY ASSET SALE TERM LOAN | ||||||||||||||||||||
| LOCATION | COUNT | CLOSING | SQUARE FEET | LEASED % | SALE PRICE | |||||||||||||||
Tampa, FL & Miami, FL 3 | 2 | 1/12/2023 | 224,037 | 100 | % | $93,250 | ||||||||||||||
Dallas, TX 4 | 1 | 1/30/2023 | 36,691 | 100 | % | 19,210 | ||||||||||||||
| Total | 3 | 260,728 | 100 | % | $112,460 | |||||||||||||||
| ADDITIONAL DISPOSITION ACTIVITY | ||||||||||||||||||||
| LOCATION | COUNT | CLOSING | SQUARE FEET | LEASED % | SALE PRICE | |||||||||||||||
| St. Louis, MO | 1 | 2/10/2023 | 6,500 | 100 | % | $350 | ||||||||||||||
| Los Angeles, CA | 1 | 3/23/2023 | 37,165 | 100 | % | 21,000 | ||||||||||||||
Los Angeles, CA 5 | 1 | 3/30/2023 | 147,078 | 99 | % | 75,000 | ||||||||||||||
Los Angeles, CA 6 | - | 5/12/2023 | - | — | % | 3,300 | ||||||||||||||
| Albany, NY | 1 | 6/30/2023 | 40,870 | 96 | % | 10,000 | ||||||||||||||
| Houston, TX | 1 | 8/2/2023 | 57,170 | 88 | % | 8,320 | ||||||||||||||
| Total | 5 | 288,783 | 97 | % | $117,970 | |||||||||||||||
| YTD total disposition activity | 549,511 | $230,430 | ||||||||||||||||||
YTD average cap rate 7 | 6.4 | % | ||||||||||||||||||
1Includes joint venture acquisitions at full acquisition price.
2For acquisitions, cap rate represents the forecasted first year NOI divided by purchase price. Does not include fees earned related to the unconsolidated joint venture.
3Includes two properties, sold in two separate transactions to the same buyer on the same date.
4Values and square feet are represented at 100%. The Company retained a 40% ownership interest in the joint venture that purchased this property.
5The Company entered into a mortgage note agreement with the buyer for $45 million.
6The Company sold a land parcel totaling 0.34 acres.
7For dispositions, cap rate represents the in-place cash NOI divided by sales price.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 13 | ||||
| Re/development Activity | ||
| DOLLARS IN THOUSANDS | ||
| RE/DEVELOPMENT PROJECTS | ||||||||||||||||||||||||||
| MARKET | ASSOCIATED HEALTH SYSTEM | SQUARE FEET | CURRENT LEASED % | BUDGET | COST TO COMPLETE | PROJECT START | ESTIMATED COMPLETION/INITIAL LEASE COMMENCEMENT | |||||||||||||||||||
| Active development | ||||||||||||||||||||||||||
| Nashville, TN | Ascension | 106,194 | 50 | % | $44,000 | $7,561 | 2Q 2021 | 3Q 2023 | ||||||||||||||||||
Orlando, FL 1 | Advent Health | 156,566 | 74 | % | 65,000 | 38,993 | 1Q 2022 | 4Q 2024 | ||||||||||||||||||
| Raleigh, NC | UNC REX Health | 120,694 | 17 | % | 52,600 | 31,235 | 2Q 2022 | 4Q 2024 | ||||||||||||||||||
| Orlando, FL | Exalt Health | 45,000 | 100 | % | 25,900 | 22,204 | 1Q 2023 | 1Q 2025 | ||||||||||||||||||
| Phoenix, AZ | HonorHealth | 101,000 | 80 | % | 54,000 | 45,142 | 2Q 2023 | 2Q 2025 | ||||||||||||||||||
| Total development | 529,454 | 60 | % | $241,500 | $145,135 | |||||||||||||||||||||
| Projected stabilized yield - 6.5%-8.0% | ||||||||||||||||||||||||||
| Estimated stabilization period post completion - 12 - 36 months | ||||||||||||||||||||||||||
| Active redevelopment | ||||||||||||||||||||||||||
| Dallas, TX | Baylor Scott & White | 217,114 | 82 | % | 17,500 | 2,903 | 4Q 2020 | 4Q 2023 | ||||||||||||||||||
| Washington, DC | Inova Health | 259,290 | 78 | % | 21,200 | 17,170 | 1Q 2022 | 2Q 2024 | ||||||||||||||||||
| Houston, TX | HCA | 314,861 | 62 | % | 30,000 | 28,317 | 2Q 2023 | 4Q 2025 | ||||||||||||||||||
| Charlotte, NC | Novant Health | 169,135 | 53 | % | 18,700 | 17,421 | 3Q 2023 | 1Q 2026 | ||||||||||||||||||
| Washington, DC | Inova Health | 57,323 | 67 | % | 10,078 | 9,203 | 3Q 2023 | 1Q 2026 | ||||||||||||||||||
| Total redevelopment | 1,017,723 | 69 | % | $97,478 | $75,014 | |||||||||||||||||||||
| Projected stabilized yield - 9.0%-12.0% | ||||||||||||||||||||||||||
| Estimated stabilization period post completion - 12 - 36 months | ||||||||||||||||||||||||||
| Total active re/development projects | 1,547,177 | 66 | % | $338,978 | $220,149 | |||||||||||||||||||||
| PROSPECTIVE RE/DEVELOPMENT | |||||||||||||||||||||||||||||||||||
| MARKET | TYPE | SQUARE FEET 2 | LEASED % 3 | BUDGET | EXPECTED START | PROJECT DESCRIPTION | |||||||||||||||||||||||||||||
| Fort Worth, TX | Dev | 102,000 | 40 | % | $48,000 | 2H 2023 | New on-campus MOB | ||||||||||||||||||||||||||||
| Chicago, IL | Redev | 73,657 | 54 | % | 12,500 | 2H 2023 | On-campus MOB redevelopment | ||||||||||||||||||||||||||||
| Houston, TX | Dev | 112,000 | 60 | % | 59,000 | 2H 2023 | New on-campus MOB | ||||||||||||||||||||||||||||
| Austin, TX | Dev | 12,900 | 60 | % | 5,600 | 1H 2024 | New adjacent to campus MOB | ||||||||||||||||||||||||||||
| New York, NY | Redev | 154,476 | 70 | % | 18,600 | 1H 2024 | Two off-campus MOBs redevelopment | ||||||||||||||||||||||||||||
| Denver, CO | Dev | 230,000 | 100 | % | 150,000 | 2H 2024 | New surgical facility and MOB adjacent to campus | ||||||||||||||||||||||||||||
| Total prospective re/development | 685,033 | 72 | % | $293,700 | |||||||||||||||||||||||||||||||
1Investment is a construction loan with purchase rights upon completion.
2If project is identified as development (dev), then amount is projected building size. If project is a redevelopment (redev), then amount is existing building size.
3If project is identified as dev, then amount is expected preleasing percentage. If project is a redev, then amount is equal to current actual leased percentage.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 14 | ||||
Portfolio 1,2 | ||
| DOLLARS IN THOUSANDS | ||
| MARKETS | |||||||||||||||||||||||||||||||||||||||||||||||
| WHOLLY OWNED COUNT | SQUARE FEET | WHOLLY OWNED | |||||||||||||||||||||||||||||||||||||||||||||
| MARKET | MSA RANK | MOB | INPATIENT/SURGICAL | OFFICE | WHOLLY OWNED | JOINT VENTURES3 | TOTAL | % OF NOI | CUMULATIVE % OF NOI | ||||||||||||||||||||||||||||||||||||||
| Dallas, TX | 4 | 45 | 3,308,315 | 307,783 | 199,800 | 3,815,898 | 226,076 | 4,041,974 | 9.8 | % | 9.8 | % | |||||||||||||||||||||||||||||||||||
| Seattle, WA | 15 | 29 | 1,592,501 | 1,592,501 | 1,592,501 | 5.9 | % | 15.7 | % | ||||||||||||||||||||||||||||||||||||||
| Houston, TX | 5 | 34 | 2,403,175 | 150,723 | 57,170 | 2,611,068 | 2,611,068 | 4.6 | % | 20.3 | % | ||||||||||||||||||||||||||||||||||||
| Boston, MA | 11 | 18 | 964,945 | 964,945 | 964,945 | 4.5 | % | 24.8 | % | ||||||||||||||||||||||||||||||||||||||
| Denver, CO | 19 | 33 | 1,780,819 | 93,869 | 1,874,688 | 116,616 | 1,991,304 | 4.2 | % | 29.0 | % | ||||||||||||||||||||||||||||||||||||
| Los Angeles, CA | 2 | 21 | 1,034,336 | 63,000 | 104,377 | 1,201,713 | 702,453 | 1,904,166 | 4.2 | % | 33.2 | % | |||||||||||||||||||||||||||||||||||
| Charlotte, NC | 23 | 32 | 1,790,415 | 1,790,415 | 1,790,415 | 4.2 | % | 37.4 | % | ||||||||||||||||||||||||||||||||||||||
| Atlanta, GA | 8 | 28 | 1,478,336 | 1,478,336 | 1,478,336 | 3.8 | % | 41.2 | % | ||||||||||||||||||||||||||||||||||||||
| Miami, FL | 9 | 20 | 1,244,531 | 133,500 | 1,378,031 | 1,378,031 | 3.4 | % | 44.6 | % | |||||||||||||||||||||||||||||||||||||
| Nashville, TN | 35 | 12 | 1,135,678 | 108,691 | 1,244,369 | 1,244,369 | 2.8 | % | 47.4 | % | |||||||||||||||||||||||||||||||||||||
| Phoenix, AZ | 10 | 35 | 1,512,304 | 1,512,304 | 1,512,304 | 2.7 | % | 50.1 | % | ||||||||||||||||||||||||||||||||||||||
| Raleigh, NC | 41 | 27 | 1,103,648 | 1,103,648 | 1,103,648 | 2.7 | % | 52.8 | % | ||||||||||||||||||||||||||||||||||||||
| Austin, TX | 27 | 13 | 863,700 | 863,700 | 863,700 | 2.5 | % | 55.3 | % | ||||||||||||||||||||||||||||||||||||||
| Tampa. FL | 18 | 19 | 971,975 | 971,975 | 971,975 | 2.4 | % | 57.7 | % | ||||||||||||||||||||||||||||||||||||||
| Indianapolis, IN | 33 | 40 | 1,162,955 | 61,398 | 1,224,353 | 273,479 | 1,497,832 | 2.4 | % | 60.1 | % | ||||||||||||||||||||||||||||||||||||
| Chicago, IL | 3 | 7 | 712,757 | 712,757 | 712,757 | 2.2 | % | 62.3 | % | ||||||||||||||||||||||||||||||||||||||
| New York, NY | 1 | 15 | 704,415 | 704,415 | 704,415 | 2.1 | % | 64.4 | % | ||||||||||||||||||||||||||||||||||||||
| Orlando, FL | 22 | 8 | 359,477 | 186,998 | 546,475 | 546,475 | 1.9 | % | 66.3 | % | |||||||||||||||||||||||||||||||||||||
| San Francisco, CA | 13 | 6 | 452,666 | 452,666 | 110,865 | 563,531 | 1.7 | % | 68.0 | % | |||||||||||||||||||||||||||||||||||||
| Memphis, TN | 44 | 11 | 802,221 | 54,416 | 856,637 | 856,637 | 1.7 | % | 69.7 | % | |||||||||||||||||||||||||||||||||||||
| Other (53 markets) | 227 | 11,109,578 | 574,976 | 1,228,363 | 12,912,917 | 519,911 | 13,432,828 | 30.3 | % | 100.0 | % | ||||||||||||||||||||||||||||||||||||
| Total | 680 | 36,488,747 | 1,532,794 | 1,792,270 | 39,813,811 | 1,949,400 | 41,763,211 | 100.0 | % | ||||||||||||||||||||||||||||||||||||||
| Number of properties | 650 | 20 | 10 | 680 | 34 | 714 | |||||||||||||||||||||||||||||||||||||||||
| % of square feet | 91.6 | % | 3.8 | % | 4.5 | % | 100.0 | % | |||||||||||||||||||||||||||||||||||||||
| % multi-tenant | 85.6 | % | — | % | 61.7 | % | 81.2 | % | |||||||||||||||||||||||||||||||||||||||
Investment | $12,512,431 | $620,313 | $492,239 | $13,624,983 | |||||||||||||||||||||||||||||||||||||||||||
Quarterly cash NOI 1 | $182,713 | $11,602 | $6,580 | $200,895 | |||||||||||||||||||||||||||||||||||||||||||
| % of cash NOI | 90.9 | % | 5.8 | % | 3.3 | % | 100.0 | % | |||||||||||||||||||||||||||||||||||||||
| BY BUILDING TYPE | |||||||||||||||||
| WHOLLY OWNED | |||||||||||||||||
| MULTI-TENANT | SINGLE-TENANT | SUBTOTAL | JOINT VENTURE3 | TOTAL | |||||||||||||
| Number of properties | 544 | 136 | 680 | 34 | 714 | ||||||||||||
| Square feet | 32,325,050 | 7,488,761 | 39,813,811 | 1,949,400 | 41,763,211 | ||||||||||||
| % of square feet | 77.4 | % | 17.9 | % | 95.3 | % | 4.7 | % | 100.0 | % | |||||||
Investment 1 | $10,569,841 | $3,055,142 | $13,624,983 | $357,555 | $13,982,538 | ||||||||||||
Quarterly cash NOI 1 | $152,204 | $48,691 | $200,895 | $4,957 | $205,852 | ||||||||||||
| % of cash NOI | 73.9 | % | 23.7 | % | 97.6 | % | 2.4 | % | 100.0 | % | |||||||
1Gross investment and quarterly cash NOI are reflected at the Company's ownership percentage.
2Excludes assets held for sale, land held for development, construction in progress and corporate property.
3The Company's weighted average ownership percentage in its joint ventures was approximately 44%.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 15 | ||||
Health Systems 1 | ||
| MOB PORTFOLIO | ||||||||||||||||||||||||||||||||
| BUILDING SQUARE FEET | # OF BLDGS | LEASED BY HEALTH SYSTEM | % OF LEASED SF | # OF LEASES | ||||||||||||||||||||||||||||
| HEALTH SYSTEM | SYSTEM RANK 2 | CREDIT RATING | ON/ADJACENT 3 | OFF-CAMPUS AFFILIATED 4 | TOTAL | % OF NOI | ||||||||||||||||||||||||||
| HCA | 1 | BBB-/Baa3 | 2,320,009 | 779,288 | 3,099,297 | 47 | 8.5 | % | 782,919 | 2.5 | % | 131 | ||||||||||||||||||||
| CommonSpirit | 4 | A-/Baa1 | 1,906,957 | 593,550 | 2,500,507 | 43 | 6.8 | % | 901,985 | 2.8 | % | 162 | ||||||||||||||||||||
| Baylor Scott & White | 21 | AA-/Aa3 | 2,570,180 | 66,376 | 2,636,556 | 29 | 6.3 | % | 1,259,418 | 4.0 | % | 193 | ||||||||||||||||||||
| Ascension Health | 3 | AA+/Aa2 | 2,156,369 | 97,551 | 2,253,920 | 24 | 5.6 | % | 926,063 | 2.9 | % | 142 | ||||||||||||||||||||
| Advocate Health | 14 | AA/Aa3 | 845,512 | 496,198 | 1,341,710 | 21 | 4.1 | % | 1,120,427 | 3.5 | % | 94 | ||||||||||||||||||||
| Tenet Healthcare Corporation | 6 | B+/B1 | 1,342,222 | 415,482 | 1,757,704 | 34 | 3.7 | % | 411,172 | 1.3 | % | 84 | ||||||||||||||||||||
| AdventHealth | 11 | AA/Aa2 | 797,587 | 118,585 | 916,172 | 14 | 2.6 | % | 411,598 | 1.3 | % | 81 | ||||||||||||||||||||
| Wellstar Health System | 75 | A+/A2 | 896,773 | 23,088 | 919,861 | 18 | 2.6 | % | 581,533 | 1.8 | % | 81 | ||||||||||||||||||||
| UW Medicine (Seattle) | 91 | AA+/Aaa | 461,363 | 169,709 | 631,072 | 10 | 2.5 | % | 294,971 | 0.9 | % | 32 | ||||||||||||||||||||
| Community Health Systems | 8 | CCC+/Caa1 | 954,317 | — | 954,317 | 24 | 2.3 | % | 387,467 | 1.2 | % | 51 | ||||||||||||||||||||
| Trinity Health | 7 | AA-/Aa3 | 678,920 | 127,868 | 806,788 | 12 | 2.1 | % | 458,080 | 1.4 | % | 59 | ||||||||||||||||||||
| Baptist Memorial Health Care | 89 | A-2/-- | 544,122 | 252,414 | 796,536 | 10 | 1.9 | % | 436,497 | 1.4 | % | 59 | ||||||||||||||||||||
| Providence St. Joseph Health | 5 | A/A2 | 330,287 | 31,601 | 361,888 | 8 | 1.6 | % | 111,557 | 0.4 | % | 24 | ||||||||||||||||||||
| Cedars-Sinai Health Systems | 51 | AA-/Aa3 | 199,701 | 90,607 | 290,308 | 5 | 1.6 | % | 52,891 | 0.2 | % | 19 | ||||||||||||||||||||
| Hawaii Pacific Health | 181 | --/A1 | 173,502 | 124,925 | 298,427 | 3 | 1.4 | % | 98,398 | 0.3 | % | 39 | ||||||||||||||||||||
| Banner Health | 24 | AA-/-- | 749,075 | 31,039 | 780,114 | 24 | 1.3 | % | 147,178 | 0.5 | % | 38 | ||||||||||||||||||||
| WakeMed | 185 | --/A2 | 368,046 | 101,597.00 | 469,643 | 12 | 1.3 | % | 137,928 | 0.4 | % | 19 | ||||||||||||||||||||
| Overlake Health System | 291 | A/Baa1 | 230,710 | — | 230,710 | 3 | 1.2 | % | 73,676 | 0.2 | % | 8 | ||||||||||||||||||||
| Bon Secours Health System | 22 | A+/A1 | 405,945 | — | 405,945 | 6 | 1.2 | % | 239,167 | 0.8 | % | 50 | ||||||||||||||||||||
| MedStar Health | 45 | A/A2 | 326,129 | — | 326,129 | 4 | 1.1 | % | 203,507 | 0.6 | % | 66 | ||||||||||||||||||||
| Boston Medical Center Corp | 204 | BBB/Baa2 | 161,254 | — | 161,254 | 1 | 1.1 | % | 86,947 | 0.3 | % | 9 | ||||||||||||||||||||
| Other (64 credit rated) | 6,705,608 | 3,748,325 | 10,453,933 | 206 | 26.9 | % | 4,582,629 | 14.5 | % | |||||||||||||||||||||||
Subtotal - credit rated 5 | 25,124,588 | 7,268,203 | 32,392,791 | 558 | 87.7 | % | 13,706,008 | 43.2 | % | |||||||||||||||||||||||
Other non-credit rated 6 | 1,121,046 | 556,355 | 1,677,401 | 33 | 5.7 | % | 851,436 | 2.7 | % | |||||||||||||||||||||||
Off-campus non-affiliated 7 | — | 2,418,555 | 2,418,555 | 59 | 6.6 | % | — | — | % | |||||||||||||||||||||||
| Wholly-owned | 26,245,634 | 10,243,113 | 36,488,747 | 650 | 100.0 | % | 14,557,444 | 45.9 | % | |||||||||||||||||||||||
| Joint ventures | 1,143,456 | 579,868 | 1,723,324 | |||||||||||||||||||||||||||||
| Total | 27,389,090 | 10,822,981 | 38,212,071 | |||||||||||||||||||||||||||||
1Excludes construction in progress and assets classified as held for sale.
2Ranked by revenue based on Modern Healthcare's Healthcare Systems Financials Database.
3The Company defines an adjacent property as being no more than 0.25 miles from a hospital campus.
4Includes off-campus buildings where health systems lease 20% or more of the property and/or are located within 2 miles from a hospital campus.
5Based on square footage, 80.5% is associated and 40.5% is leased by an investment-grade rated healthcare provider.
6Includes 33 properties associated with a hospital system that is not credit rated.
7Includes off-campus buildings that are not 20% or more leased by a health system and are more than two miles from a hospital campus.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 16 | ||||
MOB Proximity to Hospital 1,2 | ||
| MOB BY LOCATION | |||||||||||||||||
| # OF PROPERTIES | SQUARE FEET | TOTAL | % GROUND LEASED | ||||||||||||||
| On campus | 233 | 18,021,863 | 47.2 | % | 37.3 | % | |||||||||||
Adjacent to campus 3 | 203 | 9,367,227 | 24.5 | % | 4.0 | % | |||||||||||
| Total on/adjacent | 436 | 27,389,090 | 71.7 | % | 41.3 | % | |||||||||||
Off campus - affiliated 4 | 179 | 8,271,065 | 21.6 | % | 4.0 | % | |||||||||||
| Off campus | 62 | 2,551,916 | 6.7 | % | 0.6 | % | |||||||||||
| 677 | 38,212,071 | 100.0 | % | 45.9 | % | ||||||||||||
| Wholly-owned | 650 | 36,488,747 | |||||||||||||||
| Joint ventures | 27 | 1,723,324 | |||||||||||||||
MOB BY CLUSTER 5 | |||||||||||||||||||||||
| TOTAL | HOSPITAL CENTRIC 6 | ||||||||||||||||||||||
| # OF PROPERTIES | SQUARE FEET | % OF MOB SQUARE FEET | # OF PROPERTIES | SQUARE FEET | % OF MOB SQUARE FEET | ||||||||||||||||||
| Clustered | 481 | 26,478,717 | 69.3 | % | 398 | 23,130,494 | 72.0 | % | |||||||||||||||
| Non-clustered | 196 | 11,733,354 | 30.7 | % | 134 | 9,011,004 | 28.0 | % | |||||||||||||||
| Total | 677 | 38,212,071 | 100.0 | % | 532 | 32,141,498 | 100.0 | % | |||||||||||||||
1Includes joint venture properties and excludes construction in progress and assets classified as held for sale.
2Proximity to hospital campus includes acute care hospitals with inpatient beds. The Company does not consider inpatient rehab hospitals (IRFs), skilled nursing facilities (SNFs) or long-term acute care hospitals (LTACHs) to be hospital campuses for distance calculations.
3The Company defines an adjacent property as being no more than 0.25 miles from a hospital campus.
4Includes off-campus buildings where health systems lease 20% or more of the property and/or are located within 2 miles from a hospital campus.
5A cluster is defined as at least two properties within a geographic radius of two miles. The Company believes clusters provide operational efficiencies and greater local leasing knowledge that accelerate NOI growth.
6Includes buildings that are located within two miles of a hospital campus.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 17 | ||||
Lease Maturity & Occupancy1 | ||
| LEASE MATURITY SCHEDULE | |||||||||||||||||
| SQUARE FEET | % OF LEASED TOTAL SQUARE FEET | ||||||||||||||||
| # OF LEASES | MULTI-TENANT 2 | SINGLE-TENANT | TOTAL | ||||||||||||||
| 2023 | 874 | 2,345,156 | 213,859 | 2,559,015 | 7.4 | % | |||||||||||
| 2024 | 1,342 | 4,466,255 | 910,510 | 5,376,765 | 15.5 | % | |||||||||||
| 2025 | 1,081 | 3,591,654 | 992,940 | 4,584,594 | 13.2 | % | |||||||||||
| 2026 | 929 | 3,457,691 | 484,579 | 3,942,270 | 11.3 | % | |||||||||||
| 2027 | 845 | 3,253,576 | 999,428 | 4,253,004 | 12.2 | % | |||||||||||
| 2028 | 644 | 2,432,882 | 662,687 | 3,095,569 | 8.9 | % | |||||||||||
| 2029 | 396 | 1,739,641 | 715,371 | 2,455,012 | 7.1 | % | |||||||||||
| 2030 | 348 | 1,725,861 | 732,738 | 2,458,599 | 7.1 | % | |||||||||||
| 2031 | 234 | 976,122 | 242,739 | 1,218,861 | 3.5 | % | |||||||||||
| 2032 | 286 | 1,780,353 | 334,424 | 2,114,777 | 6.1 | % | |||||||||||
| Thereafter | 315 | 1,739,597 | 985,638 | 2,725,235 | 7.7 | % | |||||||||||
| Total occupied | 7,294 | 27,508,788 | 7,274,913 | 34,783,701 | 87.4 | % | |||||||||||
| Total building | 32,325,050 | 7,488,761 | 39,813,811 | ||||||||||||||
| Occupancy | 85.1 | % | 97.1 | % | 87.4 | % | |||||||||||
WALTR (months) 3 | 48.6 | 70.6 | 53.2 | ||||||||||||||
WALT (months) 3 | 94.9 | 142.7 | 104.9 | ||||||||||||||
| PORTFOLIO OCCUPANCY AND ABSORPTION | ||||||||||||||||||||||||||
| OCCUPANCY % | ABSORPTION (square feet in thousands) | |||||||||||||||||||||||||
| # OF PROPERTIES | SQUARE FEET | 2Q 2023 | 1Q 2023 | 2Q 2022 | SEQUENTIAL | Y-O-Y | ||||||||||||||||||||
| Merger combined same store multi-tenant | 471 | 28,010,899 | 86.5 | % | 86.5 | % | 86.4 | % | (15) | 21 | ||||||||||||||||
| Merger combined same store single-tenant | 123 | 6,813,003 | 99.5 | % | 99.5 | % | 99.5 | % | — | 5 | ||||||||||||||||
| Total merger combined same store properties | 594 | 34,823,902 | 89.0 | % | 89.0 | % | 88.9 | % | (15) | 26 | ||||||||||||||||
| Acquisitions | 62 | 2,878,385 | 87.3 | % | 87.0 | % | 87.7 | % | 9 | (31) | ||||||||||||||||
| Development completions | 4 | 265,892 | 84.9 | % | 84.9 | % | 77.7 | % | — | 37 | ||||||||||||||||
| Re/development | 12 | 1,203,543 | 55.8 | % | 59.4 | % | 66.2 | % | (43) | (124) | ||||||||||||||||
| Planned dispositions | 8 | 642,089 | 58.9 | % | 58.9 | % | 74.0 | % | — | (97) | ||||||||||||||||
| Wholly-owned | 680 | 39,813,811 | 87.4 | % | 87.5 | % | 87.9 | % | (49) | (189) | ||||||||||||||||
| Joint ventures | 34 | 1,949,400 | 87.0 | % | 87.0 | % | 87.2 | % | — | 33 | ||||||||||||||||
| Total | 714 | 41,763,211 | 87.4 | % | 87.5 | % | 87.8 | % | (49) | (156) | ||||||||||||||||
Merger combined same store leased % | 90.5 | % | ||||||||||||||||||||||||
| Total leased % | 88.9 | % | ||||||||||||||||||||||||
1Excludes joint ventures, land held for development, construction in progress, corporate property and assets classified as held for sale, unless noted otherwise.
2The average lease size in the multi-tenant portfolio is 3,951 square feet.
3WALTR = weighted average lease term remaining; WALT = weighted average lease term.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 18 | ||||
Leasing Statistics | ||
MERGER COMBINED SAME STORE RENEWALS 1 | ||||||||||||||
| Q2 2023 | TTM | |||||||||||||
MOB cash leasing spreads 2 | 3.0 | % | 3.1 | % | ||||||||||
| MOB cash leasing spreads distribution | ||||||||||||||
| < 0% spread | 6.2 | % | 7.5 | % | ||||||||||
| 0-3% spread | 16.4 | % | 19.7 | % | ||||||||||
| 3-4% spread | 62.2 | % | 55.1 | % | ||||||||||
| > 4% spread | 15.2 | % | 17.7 | % | ||||||||||
| Total | 100.0 | % | 100.0 | % | ||||||||||
| Tenant retention rate | 80.5 | % | 79.7 | % | ||||||||||
AVERAGE IN-PLACE CONTRACTUAL INCREASES 3 | ||||||||||||||||||||||||||
| MULTI-TENANT | SINGLE-TENANT | TOTAL | ||||||||||||||||||||||||
| % INCREASE | % OF BASE RENT | % INCREASE | % OF BASE RENT | % INCREASE | % OF BASE RENT | |||||||||||||||||||||
Merger combined same store 1 | 2.80 | % | 66.1 | % | 2.43 | % | 18.6 | % | 2.72 | % | 84.7 | % | ||||||||||||||
| Acquisitions | 2.75 | % | 6.3 | % | 2.90 | % | 0.5 | % | 2.77 | % | 6.9 | % | ||||||||||||||
Other 4 | 2.71 | % | 6.4 | % | 2.27 | % | 2.1 | % | 2.61 | % | 8.4 | % | ||||||||||||||
| Total | 2.79 | % | 78.8 | % | 2.43 | % | 21.2 | % | 2.71 | % | 100.0 | % | ||||||||||||||
| Escalator type | ||||||||||||||||||||||||||
| Fixed | 2.73 | % | 96.5 | % | 2.48 | % | 88.8 | % | 2.68 | % | 94.9 | % | ||||||||||||||
| CPI | 4.25 | % | 3.5 | % | 1.99 | % | 11.2 | % | 3.20 | % | 5.1 | % | ||||||||||||||
TYPE AND OWNERSHIP STRUCTURE 1 | ||||||||||||||
| MULTI-TENANT | SINGLE-TENANT | TOTAL | ||||||||||||
| Tenant type | ||||||||||||||
| Hospital | 45.6 | % | 72.1 | % | 51.0 | % | ||||||||
| Physician and other | 54.4 | % | 27.9 | % | 49.0 | % | ||||||||
| Lease structure | ||||||||||||||
| Gross | 9.0 | % | 2.9 | % | 7.8 | % | ||||||||
| Modified gross | 31.9 | % | 10.5 | % | 27.5 | % | ||||||||
| Net | 59.1 | % | 65.8 | % | 60.5 | % | ||||||||
Absolute net 5 | — | % | 20.8 | % | 4.2 | % | ||||||||
| Ownership type | ||||||||||||||
| Ground lease | 44.8 | % | 37.6 | % | 43.5 | % | ||||||||
| Fee simple | 55.2 | % | 62.4 | % | 56.5 | % | ||||||||
# OF LEASES BY SIZE 6 | |||||||||||
| LEASED SQUARE FEET | # OF LEASES | WALT | WALTR | ||||||||
| 0 - 2,500 | 3,736 | 71.5 | 36.5 | ||||||||
| 2,501 - 5,000 | 1,811 | 83.0 | 41.6 | ||||||||
| 5,001 - 7,500 | 646 | 94.5 | 46.8 | ||||||||
| 7,501 - 10,000 | 361 | 101.5 | 52.0 | ||||||||
| 10,001 + | 740 | 125.2 | 63.8 | ||||||||
| Total Leases | 7,294 | 104.9 | 53.2 | ||||||||
1Excludes recently acquired or disposed properties, construction in progress, land held for development, corporate property, planned dispositions and assets classified as held for sale.
2Excludes non-MOB renewals of 48,000 square feet and 51,000 square feet for the second quarter and trailing twelve months, respectively.
3Excludes leases with lease terms of one year or less.
4Includes redevelopment properties, development completion, and joint ventures.
5Tenant is typically responsible for operating expenses and capital obligations.
6Excludes joint ventures, land held for development, construction in progress, corporate property and assets classified as held for sale.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 19 | ||||
NOI Performance 1, 2 | ||
| DOLLARS IN THOUSANDS, EXCEPT PER SQUARE FOOT DATA | ||
| REFLECTS COMBINED COMPANY RESULTS FOR ALL PERIODS | ||
| MERGER COMBINED SAME STORE CASH NOI | |||||||||||||||||||||||||||||||||||||||||
| TTM 2023 | 2Q 2023 | 1Q 2023 | 4Q 2022 | 3Q 2022 | TTM 2022 | 2Q 2022 | 1Q 2022 | 4Q 2021 | 3Q 2021 | ||||||||||||||||||||||||||||||||
| Base revenue | $862,503 | $217,320 | $216,107 | $214,991 | $214,085 | $837,086 | $212,158 | $210,535 | $207,945 | $206,448 | |||||||||||||||||||||||||||||||
| Operating expense recoveries | 265,660 | 66,719 | 68,072 | 63,820 | 67,049 | 251,594 | 63,131 | 65,601 | 60,974 | 61,888 | |||||||||||||||||||||||||||||||
| Revenues | $1,128,163 | $284,039 | $284,179 | $278,811 | $281,134 | $1,088,680 | $275,289 | $276,136 | $268,919 | $268,336 | |||||||||||||||||||||||||||||||
| Expenses | 406,739 | 102,855 | 103,021 | 97,968 | 102,895 | 387,570 | 97,655 | 100,164 | 93,210 | 96,541 | |||||||||||||||||||||||||||||||
| Cash NOI | $721,424 | $181,184 | $181,158 | $180,843 | $178,239 | $701,110 | $177,634 | $175,972 | $175,709 | $171,795 | |||||||||||||||||||||||||||||||
Revenue per occ SF 3 | $36.41 | $36.65 | $36.66 | $36.00 | $36.32 | $35.30 | $35.62 | $35.81 | $34.92 | $34.88 | |||||||||||||||||||||||||||||||
| Margin | 63.9 | % | 63.8 | % | 63.7 | % | 64.9 | % | 63.4 | % | 64.4 | % | 64.5 | % | 63.7 | % | 65.3 | % | 64.0 | % | |||||||||||||||||||||
| Average occupancy | 89.0 | % | 89.0 | % | 89.0 | % | 89.0 | % | 88.9 | % | 88.6 | % | 88.8 | % | 88.6 | % | 88.5 | % | 88.4 | % | |||||||||||||||||||||
| Period end occupancy | 89.0 | % | 89.0 | % | 89.0 | % | 89.0 | % | 88.9 | % | 88.9 | % | 88.9 | % | 88.6 | % | 88.5 | % | 88.4 | % | |||||||||||||||||||||
| Number of properties | 594 | 594 | 594 | 594 | 594 | 594 | 594 | 594 | 594 | 594 | |||||||||||||||||||||||||||||||
| MERGER COMBINED SAME STORE GROWTH | |||||||||||||||||||||||
| YEAR-OVER-YEAR | |||||||||||||||||||||||
| TTM 2023 | 2Q 2023 | 1Q 2023 | 4Q 2022 | 3Q 2022 | |||||||||||||||||||
Revenue per occ SF 3 | 3.1 | % | 2.9 | % | 2.4 | % | 3.1 | % | 4.1 | % | |||||||||||||
| Avg occupancy (bps) | +40 | +20 | +50 | +50 | +50 | ||||||||||||||||||
| Revenues | 3.6 | % | 3.2 | % | 2.9 | % | 3.7 | % | 4.8 | % | |||||||||||||
| Base revenue | 3.0 | % | 2.4 | % | 2.6 | % | 3.4 | % | 3.7 | % | |||||||||||||
| Exp recoveries | 5.6 | % | 5.7 | % | 3.8 | % | 4.7 | % | 8.3 | % | |||||||||||||
| Expenses | 4.9 | % | 5.3 | % | 2.9 | % | 5.1 | % | 6.6 | % | |||||||||||||
| Cash NOI | 2.9 | % | 2.0 | % | 2.9 | % | 2.9 | % | 3.8 | % | |||||||||||||
| TOTAL CASH NOI | |||||||||||||||||||||||
| 2Q 2023 | 2Q 2022 | % CHANGE | TTM 2023 | TTM 2022 | % CHANGE | ||||||||||||||||||
| Merger combined same store cash NOI | 181,184 | 177,634 | 2.0 | % | 721,424 | 701,110 | 2.9 | % | |||||||||||||||
| Merger combined same store joint ventures | 2,612 | 2,424 | 7.8 | % | 9,784 | 9,186 | 6.5 | % | |||||||||||||||
| 183,796 | 180,058 | 2.1 | % | 731,208 | 710,296 | 2.9 | % | ||||||||||||||||
| Acquisitions/development completions | 14,924 | 11,991 | 24.5 | % | 55,956 | 27,793 | 101.3 | % | |||||||||||||||
| Dispositions/assets held for sale/other | 5,033 | 23,598 | (78.7 | %) | 56,034 | 105,670 | (47.0 | %) | |||||||||||||||
| Joint venture property cash NOI | 2,345 | 1,201 | 95.3 | % | 8,398 | 2,192 | 283.1 | % | |||||||||||||||
| Redevelopment | 1,642 | 1,354 | 21.3 | % | 5,807 | 3,795 | 53.0 | % | |||||||||||||||
Cash NOI | $207,740 | $218,202 | (4.8 | %) | $857,403 | $849,746 | 0.9 | % | |||||||||||||||
1Merger combined same store cash NOI compares cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale or intended for sale, properties undergoing redevelopment, and newly redeveloped or developed properties. Legacy HTA properties that met the same store criteria are included in both periods shown as if they were owned by the Company for the full analysis period.
2Excludes recently acquired or disposed properties, development completions, construction in progress, land held for development, corporate property, redevelopment properties, planned dispositions and assets classified as held for sale.
3Revenue per occ SF is calculated by dividing revenue by the average of the occupied SF for the period provided. Quarterly revenue per occ SF is annualized.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 20 | ||||
| NOI Reconciliations | ||
| DOLLARS IN THOUSANDS | ||
| BOTTOM UP RECONCILIATION | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | 3Q 2022 1 | 2Q 2022 | 1Q 2022 | 4Q 2021 | 3Q 2021 | ||||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) attributable to common stockholders | ($82,759) | ($87,125) | ($35,764) | $28,304 | $6,130 | $42,227 | $21,607 | ($2,066) | |||||||||||||||||||||||||||||||||||||||||||||
| Other income (expense) | 112,818 | 94,407 | 46,772 | (89,477) | 7,479 | (29,293) | (468) | 23,000 | |||||||||||||||||||||||||||||||||||||||||||||
| General and administrative expense | 15,464 | 14,935 | 14,417 | 16,741 | 10,540 | 11,036 | 8,901 | 8,207 | |||||||||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization expense | 183,193 | 184,479 | 185,275 | 158,117 | 55,731 | 54,041 | 51,810 | 50,999 | |||||||||||||||||||||||||||||||||||||||||||||
Other expenses 2 | (11,969) | 7,940 | 13,580 | 82,659 | 11,034 | 9,929 | 3,850 | 3,193 | |||||||||||||||||||||||||||||||||||||||||||||
| Straight-line rent expense | 1,525 | 1,537 | 1,358 | 1,260 | 378 | 378 | 382 | 380 | |||||||||||||||||||||||||||||||||||||||||||||
| Straight-line rent revenue | (9,530) | (9,782) | (11,231) | (8,975) | (1,705) | (1,587) | (1,227) | (1,550) | |||||||||||||||||||||||||||||||||||||||||||||
Other revenue 3 | (5,959) | (1,686) | (7,330) | (5,242) | (1,961) | (2,044) | (2,134) | (2,043) | |||||||||||||||||||||||||||||||||||||||||||||
| Joint venture property cash NOI | 4,957 | 4,769 | 4,579 | 3,877 | 2,551 | 2,052 | 1,331 | 1,210 | |||||||||||||||||||||||||||||||||||||||||||||
| Cash NOI | $207,740 | $209,474 | $211,656 | $187,264 | $90,177 | $86,739 | $84,052 | $81,330 | |||||||||||||||||||||||||||||||||||||||||||||
Pre-merger Legacy HTA NOI 4 | — | — | — | 27,114 | 128,025 | 127,363 | 127,253 | 124,807 | |||||||||||||||||||||||||||||||||||||||||||||
| Cash NOI including pre-merger Legacy HTA NOI | $207,740 | $209,474 | $211,656 | $214,378 | $218,202 | $214,102 | $211,305 | $206,137 | |||||||||||||||||||||||||||||||||||||||||||||
| Acquisitions/development completions | (14,924) | (14,048) | (13,856) | (13,128) | (11,991) | (8,620) | (5,264) | (1,918) | |||||||||||||||||||||||||||||||||||||||||||||
| Dispositions/assets held for sale/other | (5,033) | (8,123) | (10,987) | (17,736) | (23,598) | (25,213) | (27,250) | (29,609) | |||||||||||||||||||||||||||||||||||||||||||||
| Joint venture property cash NOI | (4,957) | (4,769) | (4,579) | (3,877) | (3,625) | (3,139) | (2,404) | (2,210) | |||||||||||||||||||||||||||||||||||||||||||||
| Redevelopment | (1,642) | (1,376) | (1,391) | (1,398) | (1,354) | (1,158) | (678) | (605) | |||||||||||||||||||||||||||||||||||||||||||||
| Merger combined same store cash NOI | $181,184 | $181,158 | $180,843 | $178,239 | $177,634 | $175,972 | $175,709 | $171,795 | |||||||||||||||||||||||||||||||||||||||||||||
| TOP DOWN RECONCILIATION | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | 3Q 2022 | 2Q 2022 | 1Q 2022 | 4Q 2021 | 3Q 2021 | ||||||||||||||||||||||||||||||||||||||||||||||
| Rental income before rent concessions | $332,992 | $328,115 | $332,652 | $301,692 | $142,073 | $139,775 | $132,853 | $132,971 | |||||||||||||||||||||||||||||||||||||||||||||
| Rent concessions | (3,312) | (4,022) | (3,253) | (2,761) | (1,441) | (1,286) | (1,139) | (1,225) | |||||||||||||||||||||||||||||||||||||||||||||
| Rental income | 329,680 | 324,093 | 329,399 | 298,931 | 140,632 | 138,489 | 131,714 | 131,746 | |||||||||||||||||||||||||||||||||||||||||||||
| Parking income | 2,370 | 2,391 | 2,413 | 2,428 | 1,919 | 1,753 | 2,134 | 2,187 | |||||||||||||||||||||||||||||||||||||||||||||
| Interest from financing receivable, net | 2,180 | 2,227 | 2,284 | 2,034 | 1,957 | 1,930 | 1,766 | 1,917 | |||||||||||||||||||||||||||||||||||||||||||||
| Exclude straight-line rent revenue | (9,530) | (9,782) | (11,231) | (8,975) | (1,705) | (1,587) | (1,227) | (1,550) | |||||||||||||||||||||||||||||||||||||||||||||
Exclude other non-cash revenue 5 | (1,018) | 3,594 | (3,059) | (2,280) | (1,142) | (1,322) | (1,325) | (1,261) | |||||||||||||||||||||||||||||||||||||||||||||
| Cash revenue | 323,682 | 322,523 | 319,806 | 292,138 | 141,661 | 139,263 | 133,062 | 133,039 | |||||||||||||||||||||||||||||||||||||||||||||
| Property operating expense | (125,395) | (122,040) | (117,009) | (112,473) | (57,010) | (57,464) | (53,032) | (55,518) | |||||||||||||||||||||||||||||||||||||||||||||
Exclude non-cash expenses 6 | 4,556 | 4,336 | 3,764 | 4,034 | 2,975 | 2,888 | 2,691 | 2,599 | |||||||||||||||||||||||||||||||||||||||||||||
| Non-controlling interest | (60) | (114) | 516 | (312) | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||
| Joint venture property cash NOI | 4,957 | 4,769 | 4,579 | 3,877 | 2,551 | 2,052 | 1,331 | 1,210 | |||||||||||||||||||||||||||||||||||||||||||||
| Cash NOI | $207,740 | $209,474 | $211,656 | $187,264 | $90,177 | $86,739 | $84,052 | $81,330 | |||||||||||||||||||||||||||||||||||||||||||||
Pre-merger Legacy HTA NOI 4 | — | — | — | 27,114 | 128,025 | 127,363 | 127,253 | 124,807 | |||||||||||||||||||||||||||||||||||||||||||||
| Cash NOI including pre-merger Legacy HTA NOI | $207,740 | $209,474 | $211,656 | $214,378 | $218,202 | $214,102 | $211,305 | $206,137 | |||||||||||||||||||||||||||||||||||||||||||||
| Acquisitions/development completions | (14,924) | (14,048) | (13,856) | (13,128) | (11,991) | (8,620) | (5,264) | (1,918) | |||||||||||||||||||||||||||||||||||||||||||||
| Dispositions/assets held for sale/other | (5,033) | (8,123) | (10,987) | (17,736) | (23,598) | (25,213) | (27,250) | (29,609) | |||||||||||||||||||||||||||||||||||||||||||||
| Joint venture property cash NOI | (4,957) | (4,769) | (4,579) | (3,877) | (3,625) | (3,139) | (2,404) | (2,210) | |||||||||||||||||||||||||||||||||||||||||||||
| Redevelopment | (1,642) | (1,376) | (1,391) | (1,398) | (1,354) | (1,158) | (678) | (605) | |||||||||||||||||||||||||||||||||||||||||||||
| Merger combined same store cash NOI | $181,184 | $181,158 | $180,843 | $178,239 | $177,634 | $175,972 | $175,709 | $171,795 | |||||||||||||||||||||||||||||||||||||||||||||
1Represents a full quarter on a combined company basis.
2Includes acquisition and pursuit costs, merger-related costs, rent reserves, above and below market ground lease intangible amortization, leasing commission amortization, non-cash adjustments for financing receivables, and ground lease straight-line rent.
3Includes management fee income, interest, above and below market lease intangible amortization, lease inducement amortization, lease termination fees, deferred financing cost amortization and principle related to investment in financing receivable, and tenant improvement overage amortization.
4Amounts include cash NOI from HTA properties, which were not included in our financial statements prior to July 20, 2022.
5Includes above and below market lease intangibles, lease inducements, lease termination fees, deferred financing cost amortization, financing receivable adjustments, and TI amortization.
6Includes above and below market ground lease intangible amortization, leasing commission amortization, and ground lease straight-line rent.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 21 | ||||
| NOI Reconciliations | ||
| DOLLARS IN THOUSANDS | ||
| RECONCILIATION OF NOI TO FULL QUARTER FFO AND NORMALIZED FFO | ||||||||||||||||||||||||||||||||||||||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | ||||||||||||||||||||||||||||||||||||
| Cash NOI | $207,740 | $209,474 | $211,656 | |||||||||||||||||||||||||||||||||||
| General and administrative expense | (15,464) | (14,935) | (14,417) | |||||||||||||||||||||||||||||||||||
| Straight-line rent | 9,530 | 9,782 | 11,231 | |||||||||||||||||||||||||||||||||||
| Interest and other income (expense), net | 592 | 547 | (1,168) | |||||||||||||||||||||||||||||||||||
| Management fees and other income | 1,860 | 2,227 | 2,023 | |||||||||||||||||||||||||||||||||||
| Note receivable interest income | 2,180 | 1,987 | 1,943 | |||||||||||||||||||||||||||||||||||
Other non-cash revenue 1 | 1,918 | (2,526) | 3,059 | |||||||||||||||||||||||||||||||||||
Other non-cash expenses 2 | (4,556) | (4,336) | (3,764) | |||||||||||||||||||||||||||||||||||
| Non-real estate impairment | — | (5,196) | — | |||||||||||||||||||||||||||||||||||
| Unconsolidated JV adjustments | (185) | (357) | (143) | |||||||||||||||||||||||||||||||||||
| Debt Covenant EBITDA | $203,615 | $196,667 | $210,420 | |||||||||||||||||||||||||||||||||||
| Interest expense | (65,334) | (63,759) | (64,443) | |||||||||||||||||||||||||||||||||||
| Loss on extinguishment of debt | — | — | 119 | |||||||||||||||||||||||||||||||||||
| Acquisition and pursuit costs | (669) | (287) | (92) | |||||||||||||||||||||||||||||||||||
| Merger-related costs | 15,670 | (4,855) | (10,777) | |||||||||||||||||||||||||||||||||||
Leasing commission amortization 3 | 3,335 | 3,002 | 2,706 | |||||||||||||||||||||||||||||||||||
| Non-real estate depreciation and amortization | (1,525) | (1,372) | (1,323) | |||||||||||||||||||||||||||||||||||
| Non controlling interest | (1,027) | (1,067) | (382) | |||||||||||||||||||||||||||||||||||
| Unconsolidated JV adjustments | (377) | (351) | (327) | |||||||||||||||||||||||||||||||||||
| FFO | $153,688 | $127,978 | $135,901 | |||||||||||||||||||||||||||||||||||
| Acquisition and pursuit costs | 669 | 287 | 92 | |||||||||||||||||||||||||||||||||||
| Merger-related costs | (15,670) | 4,855 | 10,777 | |||||||||||||||||||||||||||||||||||
| Lease intangible amortization | 240 | 146 | 137 | |||||||||||||||||||||||||||||||||||
| Significant non-recurring legal fees/forfeited earnest money received | 275 | — | 194 | |||||||||||||||||||||||||||||||||||
| Debt financing costs | — | — | 625 | |||||||||||||||||||||||||||||||||||
| Merger-related fair value adjustment | 10,554 | 10,864 | 11,979 | |||||||||||||||||||||||||||||||||||
| Allowance for credit losses | — | 8,599 | — | |||||||||||||||||||||||||||||||||||
| Unconsolidated JV normalizing items | 93 | 117 | 96 | |||||||||||||||||||||||||||||||||||
| Normalized FFO | $149,849 | $152,846 | $159,801 | |||||||||||||||||||||||||||||||||||
1Includes above and below market lease intangibles, interest income related to sales-type leases, lease inducements, lease termination fees, deferred financing cost amortization, and principle related to investment in financing receivable and TI amortization.
2Includes above and below market ground lease intangible amortization, leasing commission amortization, and ground lease straight-line rent.
3Leasing commission amortization is included in the real estate depreciation and amortization add-back for FFO.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 22 | ||||
| EBITDA Reconciliations | ||
| DOLLARS IN THOUSANDS | ||
| RECONCILIATION OF EBITDA | ||||||||||||||||||||
| 2Q 2023 | 1Q 2023 | 4Q 2022 | ||||||||||||||||||
| Net income | ($82,759) | ($87,125) | ($35,764) | |||||||||||||||||
| Interest expense | 65,334 | 63,759 | 64,443 | |||||||||||||||||
| Depreciation and amortization | 183,193 | 184,479 | 185,275 | |||||||||||||||||
| Unconsolidated JV depreciation,amortization,and interest | 4,789 | 5,192 | 4,339 | |||||||||||||||||
| EBITDA | $170,557 | $166,305 | $218,293 | |||||||||||||||||
| Leasing commission amortization | 3,335 | 3,002 | 2,706 | |||||||||||||||||
| Gain on sales of real estate properties | (7,156) | (1,007) | (73,083) | |||||||||||||||||
| Impairments on real estate properties | 55,215 | 26,227 | 54,452 | |||||||||||||||||
EBITDAre 1 | $221,951 | $194,527 | $202,368 | |||||||||||||||||
| EBITDA | $170,557 | $166,305 | $218,293 | |||||||||||||||||
| Acquisition and pursuit costs | 669 | 287 | 92 | |||||||||||||||||
| Merger-related costs | (15,670) | 4,855 | 10,777 | |||||||||||||||||
| Gain on sales of real estate properties | (7,156) | (1,007) | (73,083) | |||||||||||||||||
| Impairments on real estate assets | 55,215 | 26,227 | 54,452 | |||||||||||||||||
| Loss on extinguishment of debt | — | — | (119) | |||||||||||||||||
| Unconsolidated JV adjustments | — | — | 8 | |||||||||||||||||
| Debt Covenant EBITDA | $203,615 | $196,667 | $210,420 | |||||||||||||||||
| Leasing commission amortization | 3,335 | 3,002 | 2,706 | |||||||||||||||||
| Lease intangible amortization | 240 | 147 | 137 | |||||||||||||||||
Acquisition/disposition timing impact 2 | (184) | (945) | (1,704) | |||||||||||||||||
| Stock based compensation | 3,924 | 3,745 | 3,573 | |||||||||||||||||
Allowance for credit losses 3 | — | 8,599 | — | |||||||||||||||||
| Rent reserves, net | (54) | 1,371 | (100) | |||||||||||||||||
| Unconsolidated JV adjustments | 93 | 117 | 96 | |||||||||||||||||
| Adjusted EBITDA | $210,969 | $212,703 | $215,128 | |||||||||||||||||
1Earnings before interest, taxes, depreciation and amortization for real estate ("EBITDAre") is an operating performance measure adopted by NAREIT. NAREIT defines EBITDAre equal to “net income (computed in accordance with GAAP) plus interest expense, income tax expense, depreciation and amortization, impairments and minus gains on the disposition of depreciated property.”
2Adjusted to reflect quarterly EBITDA from properties acquired or disposed in the quarter.
3 In Q1 2023, allowance for credit losses included a $5.2 million credit allowance for a mezzanine loan included in "Impairment of real estate and credit loss reserves" on the Statement of Income and $3.4 million reserve included in “Rental Income” on the Statement of Income for previously deferred rent and straight line rent for three skilled nursing facilities.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 23 | ||||
| Components of Net Asset Value | ||
| DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA | ||
| CASH NOI BY PROPERTY TYPE | ||||||||||||||||||||||||||
| 2Q 2023 | ||||||||||||||||||||||||||
| ASSET TYPE | MERGER COMBINED SAME STORE 1 | ACQ./DEV. COMPLETIONS 2 | JOINT VENTURE | REDEVELOPMENT | TIMING/OTHER ADJUSTMENTS 3 | ADJUSTED CASH NOI | ANNUALIZED ADJUSTED NOI | |||||||||||||||||||
| MOB/Outpatient | $163,897 | $14,924 | $4,087 | $1,642 | $3,378 | $187,928 | $751,712 | |||||||||||||||||||
| Inpatient/Surgical | 10,517 | — | 870 | — | — | 11,387 | 45,548 | |||||||||||||||||||
| Office | 6,770 | — | — | — | 6,770 | 27,080 | ||||||||||||||||||||
| Total Cash NOI | $181,184 | $14,924 | $4,957 | $1,642 | $3,378 | $206,085 | $824,340 | |||||||||||||||||||
| DEVELOPMENT PROPERTIES | TOTAL SHARES OUTSTANDING | |||||||||||||||||||
| Land held for development | $69,575 | As of June 30, 2023 7 | 384,900,525 | |||||||||||||||||
| Re/development budget | 338,978 | |||||||||||||||||||
| $408,553 | IMPLIED CAP RATE | |||||||||||||||||||
| STOCK PRICE | IMPLIED CAP RATE | |||||||||||||||||||
As of June 30, 2023 7 | $18.96 | 6.8 | % | |||||||||||||||||
| OTHER ASSETS | ||||||||||||||||||||
| Planned dispositions | $131,187 | 2Q 2023 High | $20.14 | 6.6 | % | |||||||||||||||
Unstabilized properties 4 | 356,309 | 2Q 2023 Low | $18.02 | 7.0 | % | |||||||||||||||
Cash and other assets 5 | 379,433 | |||||||||||||||||||
| $866,929 | ||||||||||||||||||||
| DEBT | ||||||||||||||||||||
| Unsecured credit facility | $354,000 | |||||||||||||||||||
| Unsecured term loans | 1,500,000 | |||||||||||||||||||
| Senior notes | 3,699,500 | |||||||||||||||||||
| Mortgage notes payable | 82,783 | |||||||||||||||||||
| Company share of joint venture debt | 27,640 | |||||||||||||||||||
| Remaining re/development funding | 220,149 | |||||||||||||||||||
Other liabilities 6 | 232,602 | |||||||||||||||||||
| $6,116,674 | ||||||||||||||||||||
1See NOI Performance schedule on page 20 for details on same store NOI.
2Adjusted to reflect quarterly NOI from properties acquired or stabilized re/developments completed during the full eight quarter period that are not included in same store NOI.
3Timing adjustments include adjustments to reflect re/development completion adjustments of $1.0 million, and management fee income of $1.5 million. This is partially offset by $1.8 million of positive NOI for unstabilized properties, which are shown in other assets.
4Includes 41 properties at their gross book value. These properties were comprised of 1.6 million square feet that generated positive NOI of $0.9 million.
5Includes cash of $35.9 million, notes receivable of $151.5 million, prepaid assets of $90.0 million, accounts receivable of $58.2 million, prepaid ground leases of $20.2 million, and other investments of $6.0 million. In addition, includes the Company's occupied portion of its corporate headquarters in Nashville and Charleston of $17.6 million.
6Includes only liabilities that are expected to reduce future cash or NOI and that are currently producing non-cash benefits to NOI. Included are accounts payable and accrued liabilities of $196.1 million, security deposits of $30.2 million, and deferred operating expense reimbursements of $6.3 million.
7Total shares outstanding includes OP units.
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 24 | ||||
| Components of Expected FFO | ||
| DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA | ||
| EXPECTED 2023 | ACTUAL | ||||||||||||||||||||||
| LOW | HIGH | Q2 2023 | TTM | ||||||||||||||||||||
| MERGER COMBINED SAME STORE | |||||||||||||||||||||||
Multi-tenant average absorption (bps) | 50 | 100 | 30 | 60 | |||||||||||||||||||
| Revenue per occupied square foot | $36.25 | $37.00 | $36.65 | $36.41 | |||||||||||||||||||
Cash NOI margin | 63.5 | % | 64.5 | % | 63.8 | % | 63.9 | % | |||||||||||||||
| Cash leasing spreads | 3.0 | % | 4.0 | % | 3.0 | % | 3.1 | % | |||||||||||||||
| Lease retention rate | 75.0 | % | 90.0 | % | 80.5 | % | 79.7 | % | |||||||||||||||
Cash NOI growth, including Company's share of JVs | 2.0 | % | 3.0 | % | 2.1 | % | 2.9 | % | |||||||||||||||
| ANNUAL EXPECTATIONS | LOW | HIGH | YTD | ||||||||||||||||||||
| NON-SAME STORE | |||||||||||||||||||||||
| Normalized G&A | 59,000 | 61,000 | 30,124 | ||||||||||||||||||||
| Straight-line rent, net | 28,000 | 32,000 | 16,251 | ||||||||||||||||||||
| Funding activity | |||||||||||||||||||||||
| Acquisitions | $50,000 | $100,000 | 42,950 | ||||||||||||||||||||
| Dispositions to repay asset sale term loan | 112,460 | 112,460 | 112,460 | ||||||||||||||||||||
| Additional dispositions | 350,000 | 450,000 | 117,970 | ||||||||||||||||||||
| Re/development | 100,000 | 125,000 | 48,996 | ||||||||||||||||||||
| 1st generation TI and acq. capex | 45,000 | 85,000 | 22,128 | ||||||||||||||||||||
| Maintenance capex | |||||||||||||||||||||||
| 2nd generation TI | 50,000 | 60,000 | 26,118 | ||||||||||||||||||||
| Leasing commissions paid | 30,000 | 35,000 | 12,506 | ||||||||||||||||||||
| Capital expenditures | 60,000 | 65,000 | 17,595 | ||||||||||||||||||||
| Total maintenance capex | 140,000 | 160,000 | 56,219 | ||||||||||||||||||||
| Cash yield | |||||||||||||||||||||||
| Acquisitions | 6.0 | % | 6.5 | % | 6.5 | % | |||||||||||||||||
| Dispositions | 6.0 | % | 7.0 | % | 6.4 | % | |||||||||||||||||
| Development (stabilized) | 6.5 | % | 8.0 | % | |||||||||||||||||||
| Redevelopment (stabilized) | 9.0 | % | 12.0 | % | |||||||||||||||||||
| Net debt to adjusted EBITDA | 6.0x | 6.5x | 6.6x | ||||||||||||||||||||
| Net income (loss) attributable to common stockholders per share | $(0.75) | $(1.00) | $(0.45) | ||||||||||||||||||||
Normalized FFO per share | $1.57 | $1.60 | $0.79 | ||||||||||||||||||||
HEALTHCARE REALTY | 2Q 2023 SUPPLEMENTAL INFORMATION 25 | ||||